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The rapid growth of the number of antibiotic-resistant strains of pathogenic 
bacteria is becoming a major threat to global public health. In order to limit the number 
of deaths from simple infections, the development of target specific drugs to replace 
conventional antibiotic therapies is urgently needed. One of the most promising 
approaches is based on interrupting iron assimilation in pathogenic bacteria. 
Isochorismate synthase DhbC from Bacillus anthracis is important for the infectivity of 
this dangerous bacterium because it catalyzes the first step in the pathway for synthesis 
of the siderophore, bacillibactin. Pathogenic bacteria use siderophores, chelating ferric 
ions chemical compounds, in order to assimilate scarcely available ferric ions inside of 
the host organism. The DhbC active site is very similar to the active sites of other 
chorismate-utilizing enzymes, which suggests the possibility of developing a single 
inhibitor that targets multiple chorismate-utilizing enzymes. Chorismate-utilizing 
enzymes are very promising antimicrobial drug targets because of their important role in 
virulence and in a wide range of bacterial metabolic processes, plus their absence in 
humans. Therefore, Center of Structural Genomics of Infectious Diseases (CSGID) 
selected DhbC as a target for structural studies. 
Structural genomics (SG) is a relatively new approach to structural biology (first 
projects started in late 90’s) aimed at high-throughput 3D structure determination of 
macromolecules. Typical SG center consist of specialized laboratories that perform only 
selected parts of the protein structure determination experimental pipeline. In most of 
the cases, including CSGID, involved laboratories are located in distant research 
centers. In order to control the vast amount of data produced by the consortium, the data 
management system LabDB/UniTrack was developed in Wladek Minor’s laboratory at 
the University of Virginia. The system tracks all experimental work and exchange the 
data within the lab (group) and between groups involved in the project.  
The main scientific objective of my work was to determine the three-
dimensional structure of the isochorismate synthase DhbC from B. anthracis and 
subsequently biochemical characterization of this enzyme. The atomic structure of this 
enzyme will be used for identification of new inhibitors of catecholate siderophore 





develop components of the innovative data management system for structural genomics 
UniTrack, i.e., the protein target tracking database CSGID-DB, associated knowledge 
dissemination web portal, target validation tool, and communication protocols with 
other databases. UniTrack is an important part of CSGID gene-to-structure high-
throughput pipeline. 
The structure of the apo form of DhbC from B. anthracis was solved using 
single crystal X-ray diffraction at 2.4 Å resolution. DhbC adopts the characteristic fold 
of other chorismate-utilizing enzymes, and strongly resembles isochorismate synthase 
EntC from Escherichia coli. The enzyme is a homodimer and requires presence of Mg
2+
 
ions for its activity. Enzyme kinetics constants were determined using 
spectrophotometric assay. 
The UniTrack system monitors all the experimental work on particular protein 
targets and provides intuitive workflow between research groups involved in the project. 
It also reports general progress of the consortium by generating real-time internal 
reports and statistics as well as XML files, which are used for data submission to 
external repositories. Moreover, it serves as an information hub for the infectious 
disease scientific community. In 2011, three other structural genomics consortia, the 
Midwest Center for Structural Genomics, New York Structural Genomics Research 
Consortium, and the Enzyme Function Initiative incorporated the UniTrack system for 
the purpose of data management. To date in CSGID only, over 700 protein structures 
have been determined with use of the UniTrack and ~7000 protein targets are 






Gwałtowny wzrost liczby odpornych na antybiotyki szczepów patogennych 
bakterii staje sie głównym zagrożeniem dla globalnego zdrowia publicznego. W celu 
ograniczenia liczby zgonów spowodowanych przez proste infekcje, potrzebny jest 
natychmiastowy rozwój swoistych leków w celu zastąpienia konwencjonalnych terapii 
antybiotykowych. Jedno z najbardziej obiecujących podejść jest ukierunkowane na 
uniemożliwienie asymilacji żelaza przez patogenne bakterie. Syntaza izochorizmianu 
DhbC z Bacillus anthracis jest ważnym dla infekcyjności tej groźnej bakterii enzymem 
katalizującym pierwszy etap w szlaku syntezy sideroforu, bacillobaktyny. Patogenne 
bakterie używają sideroforów, chelatującyh jony żelazowe związków chemicznych, w 
celu asymilowania trudno dostępnych jonów żelazowych wewnątrz organizmu 
gospodarza. Centrum aktywne DhbC jest bardzo podobne do centrów aktywnych 
innych enzymów wykorzystujących choryzmian, sugerując możliwość opracowania 
pojedynczego inhibitora dla kilku enzymów wykorzystujących choryzmian. Enzymy 
wykorzystujące choryzmian są bardzo obiecującymi celami dla leków 
przeciwdrobnoustrojowych ze względu na ich rolę w wirulencji i w szerokim zakresie 
bakteryjnych procesów metabolicznych, oraz ich nieobecność u ludzi. Z tych powodów, 
DhbC została wyselekcjonowana do badań strukturalnych przez Centerum Genomiki 
Strukturalnej Chorób Infekcyjnych (ang. skrót CSGID). 
Genomika strukturalna (skrót: SG) jest nowym podejściem do biologii 
strukturalnej (pierwsze projekty ruszyły pod koniec lat dziewięćdziesiątych) 
polegającym na wysokoprzepustowym rozwiązywaniu trójwymiarowych struktur 
makromolekuł. W skład typowego centrum genomiki strukturalnej wchodzą 
wyspecjalizowane laboratoria przeprowadzające tylko określone etapy sekwencji 
eksperymentów prowadzącej do rozwiązania struktury białka. W większości 
przypadków, również w CSGID, wchodzące w skład centrów laboratoria są ulokowane 
w odległych ośrodkach naukowych. W celu kontrolowania olbrzymich zasobów danych 
wyprodukowanych przez konsorcjum, w laboratorium prof. Władysława Minora na 
University of Virgnia został rozwinięty system zarządzania danymi LabDB/UniTrack. 
System ten pozwala na śledzenie całości pracy doświadczalnej i wymianę tej informacji 





 Głównym celem naukowym mojej pracy było rozwiązanie trójwymiarowej 
struktury syntazy izochoryzmianu DhbC z B. anthracis, a następnie scharakteryzowanie 
biochemicznych właściwości tego enzymu. Struktura atomowa tego enzymu zostanie 
wykorzystana do poszukiwań nowych inhibitorów ścieżek metabolicznych siderofrów 
pirokatechinowych poprzez wysokoprzepustowe badania przesiewowe. Drugim celem 
było rozwinięcie komponentów innowacyjnego systemu zarządzania danymi dla 
genomiki strukturalnej UniTrack, tzn. bazy danych monitorującej postęp prac na celami 
białkowymi CSGID-DB, powiązanego portalu internetowego rozpowszechniającego 
uzyskaną wiedzę, narzędzia do walidacji celów białowych i protokołów komunikacji z 
innymi bazami danych. UniTrack jest ważną częścią wyskoprzepustowej sekwencji 
doświadczalnej “od genu do struktury”. 
Struktura formy apo DhbC z B. anthracis została rozwiązana za pomocą 
krystalografii rentgenowskiej pojedynczych kryształów makromolekuł do 
rozdzielczości 2.4 Å. DhbC przybiera zwój charakterystyczny dla innych enzymów 
wykorzystujących choryzmian i silnie przypomina syntazę izochoryzmianu EntC z 
Escherichia coli. Enzym jest homodimerem i wymaga obecności jonów Mg
2+
 dla swojej 
aktywności. Stałe kinetyczne dla reakcji katalizowanej przez enzym zostały 
wyznaczone z użyciem analizy spektrofotometrycznej. 
System UniTrack monitoruje pracę doświadczalną nad poszczególnymi celami 
białkowymi i zapewnia intuicyjny przypływ pracy pomiędzy grupami badawczymi 
zaangażowanymi w projekt. Monitoruje również ogólny postęp konsorcjum przez 
generowane w czasie rzeczywistym wewnętrzne raporty i statystyki jak również pliki 
XML, które są wysyłane do zewnętrznych repozytoriów. Ponadto sluży jako centrum 
informacyjne dla społeczności naukowej. W 2011, kolejne trzy centra genomiki 
strukturalnej: Midwest Center for Structural Genomics, New York Structural Genomics 
Research Consortium i Enzyme Function Initiative zaadoptowały system UniTrack na 
potrzeby zarzadzania danymi. Do chwili obecnej w samym CSGID, ponad 700 struktur 
białek zostało rozwiązanych z użyciem systemu UniTrack, a  około 7000 celów 





1.1 Chorismate-utilizing enzymes as putative drug 
targets 
The shikimate biosynthetic pathway, present solely in bacteria, algae, higher 
plants, fungi, and Apicomplexa (phylum of parasitic protists), produces chorismate out 
of D-erythrose 4-phosphate and phosphoenolpyruvate (PEP). Chorismate is anionic 
form of chorismic acid and serves as intermediate metabolite between the shikimate 
pathway and the following biosynthetic pathway for aromatic amino acids 
(i.e., L-phenylalanine, L-tryptophan, and L-tyrosine). Additionally, chorismate is a 
precursor for biosynthesis of multiple other aromatic compounds such as folate, 
ubiquinone, phenazines (Dosselaere and Vanderleyden 2001; Kerbarh et al. 2005), and 
selected siderophores, including enterobactin (O'Brien et al. 1970) and bacillibactin 
(May et al. 2001). The aforementioned aromatic compounds are essential for bacteria 
survival and virulence. Because mammals do not possess the above-mentioned 
pathways, the enzymes have gained attention as potential targets for the development of 
new antimicrobial drugs (Kerbarh et al. 2005; Ziebart et al. 2010). Up to the present 
time, seven distinct chorismate-utilizing enzymes have been characterized in bacteria, 
including chorismate mutase (CM), chorismate pyruvate-lyase (CPL), anthranilate 
synthase (AS), 4-amino-4-deoxychorismate synthase (ADCS), 2-amino-
2-desoxyisochorismate synthase (ADICS), isochorismate synthase (ICS), and salicylate 
synthase (SS). Five of these enzymes, i.e., ICS, SS, AS, ADICS and ADCS share 
significant structural similarity (including nearly identical actives), require Mg
2+
 ions 
for its catalytic activity, and catalyze a similar SN2 nucleophilic substitution reactions. 
Thus, it may be possible to develop single compound that will inhibit more than one of 
those enzymes (Ziebart et al. 2010).  
The isochorismate synthase DhbC from Bacillus anthracis participates in the 
bacillibactin biosynthetic pathway. In closely related species B. cereus, bacillibactin 
was recently demonstrated to be crucial for effective virulence through iron acquisition 
from host ferritin during infection in insects (Segond et al. 2014). Studies on the 





of siderophore biosynthesis and therefore drugs limiting virulence of pathogenic 
bacteria (Ferreras et al. 2005). Moreover, since bacteria recognize only certain 
siderophores, it may be possible to use siderophore-mediated iron transport as a ‘Trojan 
horse’ for very selective antimicrobial drug delivery (Roosenberg et al. 2000; 
Wencewicz et al. 2009). Coupling of the siderophore iron-binding groups to an 
antibiotic should significantly increase effectiveness of the latter one. The drug would 
be delivered directly to the pathogenic bacteria using microbe specific siderophore.  
1.1.1 Antimicrobial resistance – a major threat to public 
health 
Antimicrobial resistance (AMR) is an evolutionarily developed resistance of a 
pathogen to an antimicrobial drug that was initially effective for treatment of infections 
caused by the pathogen. Antibiotic resistance refers specifically to resistance of 
pathogenic bacteria to antibiotics. The main cause of antibiotic resistance is extensive 
and irresponsible use of antibiotics, which are not only used in medicine, but also in 
animal feed, plant agriculture, and industry (Barbosa and Levy 2000; Nikaido 2009). 
Antibiotics are produced at estimated scale of about 100,000 tons annually worldwide. 
The use of antibiotics creates selective pressure on pathogenic bacteria resulting in the 
development of resistant strains in humans and livestock animals. Humans spread the 
resistant bacteria in their families, communities and especially in hospitals and other 
health care facilities where the most of the infection related deaths occur (CDC 2013). 
In rare cases resistant bacteria are transmitted to humans from animals via consumption 
of animal products, contact with animals or by contamination of crops (Hurd et al. 2004; 
CDC 2013). The emergence of bacterial strains resistant to multiple classes of 
antibiotics, including most dangerous methicillin-resistant Staphylococcus aureus 
(MRSA), and strains resistant to all clinically relevant drugs like multidrug-resistant 
Streptococcus pneumoniae and multi-drug-resistant Mycobacterium tuberculosis is 
cause for alarm. Outbreaks of multi-drug resistant strains may lead to a global pandemic 
situation (Choffnes ER 2010). In the United States only, minimum estimates show that 
antibiotic resistant bacteria are causing ~2 million infections per year, with ~24,000 
associated deaths. Additionally, infections caused by Clostridium difficile, which 





deaths (CDC 2013). It is important to limit the number of infections through the 
promotion of good hygiene and sanitation, improvement of the use of antibiotics, and 
development of new generation of antimicrobial drugs. 
On April 30 2014, the World Health Organization released the first global report 
on antibiotic resistance. The report, ‘Antimicrobial resistance: global report on 
surveillance,’ gathers data from 114 countries in all parts of the world which makes it 
the most complete study on antimicrobial resistance to date. WHO is highlighting the 
critical actions that should be taken to overcome AMR, i.e., reinforcing global AMR 
surveillance, monitoring the effectiveness of public health, detecting trends and threads, 
and most importantly developing a global action plan against AMR (WHO 2014). 
The WHO report does not leave any doubt that antibiotic resistance has already become 
a major threat to public health. 
1.1.2 Anthrax treatment and antimicrobial resistance 
Anthrax is a potentially lethal disease caused by B. anthracis, known to 
humanity since the development of agriculture, and associated with black eschars 
caused by its cutaneous form (Turnbull 2010). The disease affects wild and 
domesticated animals (i.e., cattle, sheep, and horses) and occasionally humans. 
B. anthracis forms spores that can be infectious for many years and can be found in soil 
as well as on hair, wool, and processed skins made from infected animals. Humans 
working with farm animals and animal products are considered high-risk group for 
anthrax infection. The most common B. anthracis infections are cutaneous, and this 
anthrax form can be successfully treated using antibiotics. Inhalational infection, on the 
other hand, has fatality rate of almost 90% (Beierlein and Anderson 2011). Antrax 
infection has two stages, an intracellular establishment stage in macrophages, and a 
subsequent extracellular stage that leads to bacteremia, sepsis, and death (Cendrowski et 
al. 2004). The ability to grow within macrophages and use their trafficking during 
infection is a distinctive feature of anthrax (Bergman 2011).  
Recently, B. anthracis gained public attention after its spores were used for 
bioterror attacks that happened in September 2001 in the USA. Envelopes with spores 
of the highly virulent Ames strain of B. anthracis were mailed to news media offices 





Currently, military personnel, vulnerable laboratory workers, and livestock workers 
around the world receive one of two licensed anthrax vaccines: anthrax vaccine 
adsorbed (AVA) or anthrax vaccine precipitated (AVP). The vaccines are administered 
in multiple doses over 18 and 8-month periods respectively, and followed by annual 
booster doses to maintain the immunity (Splino et al. 2005). In case of sudden outbreak 
of anthrax, vaccines would have limited use because of the slow development of 
immunity and short period of effective protection (Weiss et al. 2007).  
Treatment of anthrax is based on prolonged use of antibiotics and it is effective 
for some forms of the disease. Similar to treatments for other bacterial infections, it 
includes large doses of intravenous and oral antibiotics, such as fluoroquinolones, 
doxycycline, erythromycin, vancomycin, or penicillin (Evans 2002). Typical post-
exposure preventative treatment is based on administration of penicillin G, amoxicillin, 
doxycycline, and ciprofloxacin or ofloxacin given for minimum 60 days (Athamna et al. 
2004). It has been showed by multiple in vitro studies that prolonged antibiotic 
treatment might induce resistance to fluoroquinolones (i.e., ciprofloxacin, ciprofloxacin, 
garenoxacin, levofloxacin and ofloxacin), doxycycline, rifampicin, and β-lactam 
antibiotics (i.e., amoxicillin, ceftriaxone, penicillin G) in B. anthracis (Pomerantsev et 
al. 1992; Brook et al. 2001; Price et al. 2003; Athamna et al. 2004). Naturally occurring 
penicillin resistance in B. anthracis has been already documented in clinical isolates 
(Severn 1976; Bradaric and Punda-Polic 1992; Lalitha and Thomas 1997). 
1.1.3 Importance of iron for pathogenic bacteria and their 
host organisms 
Iron is an abundant transition metal that is an essential cofactor for the most 
important cellular processes in practically all forms of life. The iron-dependent 
processes include photosynthesis, oxygen transport, respiration, the tricarboxylic acid 
cycle, lipid metabolism, amino acid synthesis, nucleoside synthesis, gene regulation, 
DNA synthesis, etc. (Cairo et al. 2006). Iron functions as a protein cofactor in the form 
of mononuclear and binuclear species, as well as more complex iron-sulfur clusters and 
heme groups (Andrews et al. 2003). Nevertheless, acquisition of iron is a rather 
challenging problem for organisms living in oxic environment as well as for pathogenic 





called ferrous iron and iron(III) form, referred to as ferric ion. Under aerobic conditions 
ferrous ions are unstable and react with peroxides forming free radicals which damage 
DNA, proteins and lipids (Touati 2000). Ferric ions, on the other hand, in aqueous oxic 
solutions aggregate into very insoluble ferric hydroxides, bringing down the 
concentration of soluble ferric ions to extremely low levels, i.e., 10
-18
M in pH  7.4
 
(Carrano and Raymond 1978). Moreover, free aqueous Fe
3+
 ion is toxic for the cell. For 
that reason, the level of free iron in the human body is strictly regulated and kept to a 
negligible level. In human serum, virtually all iron is either bound to hemoglobin, heme, 
or iron-storage proteins like ferritins and transferrins or serves as cofactors for various 
enzymes (Hotta et al. 2010).  
Iron is equally essential for microbes as it is for higher organisms. The virulence 
of numerous bacteria including Escherichia coli (Bullen et al. 1968), Klebsiella 
pneumonia (Ward et al. 1986), Listeria monocytogenes (Martinez et al. 1990), 
Salmonella (Griffiths 1991), Shigella (Payne 1989) and other species has been proven to 
increase with excess of iron. For example, in the case of Yersinia enterocolitica, the 
virulence was enhanced 10 million-fold after the peritoneal injection of ferric 
desferrioxamine (Bullen et al. 1991). Analogically, bacteriostatic properties of human 
milk are eliminated by in vitro addition of iron (Bullen 1972). Aforementioned studies 
indicate that strict control of iron availability in mammals is an important element of 
their protection against bacterial infection (Andrews et al. 2003). The mechanism of 
protection against microbial infection through active sequestration of nutritional 
elements is called nutritional immunity (Pishchany 2011). In the absence of highly 
efficient iron assimilation pathways, pathogenic bacteria would not be able to grow and 
would be gradually defeated by host’s immune system (Ratledge and Dover 2000). 
Therefore, pathogenic bacteria evolved sophisticated systems for assimilation of iron. 
1.1.4 Iron assimilation by B. anthracis 
The genome of B. anthracis contains significantly more iron acquisition systems 
than genomes of non-pathogenic members of the Bacillus genus (Read et al. 2003). 
It contains 16 ABC uptake systems for iron and iron-complexes and two systems for 
siderophore biosynthesis (Cendrowski et al. 2004). B. anthracis is considered an 





initiate the infection (Mock and Fouet 2001). The complex life cycle of B. anthracis and 
ability to infect the host organism through multiple entry points are possible causes of 
the diversity of iron acquisition systems this bacteria (Skaar et al. 2006). Unfortunately, 
we still do not fully understand mechanisms of action of iron acquisition systems in the 
Bacillus genus.  
In general, inside host organisms pathogenic bacteria acquire iron using multiple 
different strategies that target specific iron sources. The main approaches are iron 
acquisition from heme, hemoglobin, iron transport, storage and other heme-containing 
proteins (i.e., transferrin, lactoferrin, and ferritin) and ferric iron acquisition by small 
iron-chelating compounds, i.e., siderophores (Caza and Kronstad 2013). 
Many Gram-negative as well as Gram-positive bacteria produce siderophores, 
typically under iron limiting conditions (Krewulak and Vogel 2008). There are three 
groups of siderophores based on the chemical structure of metal binding site: 
catecholates, hydroxamates, and hydroxycarboxylates (Raymond 2004). The genus 
Bacillus produces two types of catecholate siderophores, petrobactin (also known as 
anthrachelin), which contains 3,4-dihydroxybenzoyl moieties and bacillibactin (also 
known as anthrabactin), which contains 2,3-dihydroxybenzoyl moieties. Biosynthesis of 
above-mentioned siderophores is performed by B. anthracis catechol (bac) and anthrax 
siderophore biosynthesis (asb) operons, for bacillibactin and anthrachelin respectively 
(Cendrowski et al. 2004). Bacillibactin has significantly higher affinity for ferric ions 
(Kf = 10
47.6
) (Dertz et al. 2006) than petrobactin (Kf = 10
23
) (Abergel et al. 2008), but it 
is being recognized by the immune system protein siderocalin, while petrobactin is able 
to evade this barrier (Abergel et al. 2006). Petrobactin was shown to be required for 
bacterial growth in low iron medium and for mouse virulence, while bacillibactin is 
produced in response to low iron medium but is not required for growth in that medium 
or for virulence in mice (Cendrowski et al. 2004). 
Acquisition of iron from heme sources requires destruction of red blood cells 
with toxins or hydrolytic enzymes and uptake of heme through secretion of hemophores 
(heme-binding proteins) (Caza and Kronstad 2013). During the extracellular phase of 
infection, B. anthracis is able to lyse erythrocytes and extract heme from hemoglobin 
through system known as iron-regulated surface determinant (Isd). Isd protein binds 
heme and heme-containing proteins through NEAT (NEAr iron Transporter) domains 
(Gat et al. 2008). The importance of the Isd iron acquisition system for B. anthracis 





is absent in other members of Bacillus genus except of B. cereus group. B. anthracis is 
part of the B. cereus group of bacilli, which also includes B. cereus, B. thuringiensis, 
and B. mycoides (Dixon et al. 1999). B. anthracis can grow on high concentrations of 
heme in comparison to other bacilli, in spite of toxicity of this compound (Lee et al. 
2011). Recent studies on B. cereus (Segond et al. 2014) have shown that bacillibactin, in 
cooperation with the surface ferritin receptor IlsA, is essential for iron acquisition from 
host ferritin. Lack of the bacillibactin production resulted in a drastic reduction of the 
ability to acquire iron from ferritin and attenuated virulence in insects. IslA is one of the 
NEAT proteins and is involved in both ferritin and heme/hemoglobin acquisition. B. 
anthracis has two proteins: BslL, which is nearly identical to last three fourths of IlsA 
and BslK, which shares similarity with NEAT and SLH domains of IslA. BslK was 
shown to bind heme and mediate heme delivery to Isd system (Tarlovsky et al. 2010). 
Unfortunately, involvement of these proteins in iron acquisition from ferritin has not 
been studied yet (Segond et al. 2014). 
Ferric uptake regulator (Fur) controls most of the iron acquisition systems in 
bacteria, including Bacillus genus. Fur is a transcription regulator that binds to DNA in 
the presence of a co-regulatory Fe
2+
 ion (Bagg and Neilands 1987). The protein is 17 
kDa and it functions as a homodimer where each subunit is binding single ferrous ion 
(Coy and Neilands 1991). Binding of metal ions to a Fur dimer increases its affinity to 
the DNA-binding site known as Fur box by ~ 1000 fold (Andrews et al. 2003). When 
iron levels are low, Fur dissociates from Fur boxes derepressing the transcription of 
various bacterial toxins and virulence factors (Caza and Kronstad 2013). In the 
B. cereus group, Fur regulator controls only biosynthesis of bacillibactin and not 
petrobactin (Rowland and Taber 1996; Baichoo et al. 2002).  
1.1.5 Synthesis of bacillibactin by B. anthracis 
Isochorismate synthase DhbC from B. anthracis is a product of dhbC gene, part 
of the bac operon (Bacillus anthracis catechol, BA2368-2372) (Figure 1) which encodes 
proteins responsible for the synthesis of bacillibactin (Figure 2) (Cendrowski et al. 
2004). Biosynthesis of this catechol siderophore has two stages: biosynthesis of 
2,3-dihydroxybenzoic acid (DHB) and assembling DHB to a cyclic amino acid core 





DhbEBF (May et al. 2001). DhbC catalyzes the first step of DHB biosynthesis, which is 
conversion of aromatic amino acid precursor, chorismate to isochorismate. The genome 
of B. anthracis, as well as of closely related B. subtilis, contain a second isochorismate 
synthase gene menF, located in the biosynthetic operon of respiratory chain component 
menaquinone. It has been shown that DhbC can compensate for a lack of its isozyme 
MenF, although depletion of DhbC is not compensated by MenF and results in the 
absence of DHB (Rowland and Taber 1996). In the second step of DHB biosynthesis, 
isochorismate is hydrolyzed to 2,3-dihydro-2,3-dihydroxybenzoate and pyruvate by 
isochorismate lyase (DhbB). Subsequently, 2,3-dihydro-2,3-dihydroxybenzoate is 
oxidized to DHB by 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (EntA) 
(Hoffmann et al. 2002). DHB is activated in an ATP-dependent reaction by 
2,3-dihydroxybenzoate-AMP ligase (DhbE) and transferred to free thiol group of the 
cofactor phosphopantetheine of the bifunctional isochorismatase/aryl-carrier protein 
(DhbB) (May et al. 2001). Finally, a dimodular NRPS (DhbF) specifically adenylates 
threonine and glycine, covalently links these amino acids to corresponding peptidyl 
carrier domains, amide links the two residues to 2,3-dihydroxybenzoyladenylate and 
esterifies three of these intermediates to form 2,3-dihydroxybenzoate-glycine-threonine 
trimeric ester (bacillibactin) (May et al. 2001; Hoffmann et al. 2002). The bac operon 
also contains: a gene encoding an MtbH-like protein whose function is uncertain, but is 
often associated with NRPS-assisted aryl-containing natural products; a major facilitator 
superfamily (MFS) efflux transporter (Hotta et al. 2010); the sfp gene encoding a 
4-phosphopantetheinyl transferase, essential for proper post-translational activation of 
DhbB and DhbF (Ollinger et al. 2006); and a homolog of ubiC, chorismate pyruvate 
lyase whose function in bacillibactin synthesis is unclear (Hotta et al. 2010). 
 
 
Figure 1 Structure of the bacillibactin biosynthetic operon. Blue asterisks mark genes selected for 






Analogous to E. coli enterobactin, the ferric uptake regulator Fur regulates 
bacillibactin biosynthesis. Bacillibactin is expressed only under iron-limited conditions 
(Baichoo et al. 2002), regardless of growth aeration (Lee et al. 2011). Availability of 
iron in concentration of 20 M is sufficient for nearly complete repression of the 
accumulation of bacillibactin (Ollinger et al. 2006). The bacillibactin operon is also 
upregulated by oxidative stress as the highest accumulation of bacillibactin was 
observed in conditions of low aeration and iron-depletion (Lee et al. 2011). In B. subtilis 
expression of DhbA, DhbB, DhbC, and DhbE is induced by high salinity and 
corresponding iron limitation (Hoffmann et al. 2002). 
 
Figure 2 Pathway of bacillibactin biosynthesis in B. anthracis. Reaction performed by isochorismate 
synthase DhbC was outlined with red frame. Image reprinted from an original article (Domagalski 






1.2 Protein X-ray crystallography 
Atomic structures of macromolecules are very important for studying their 
function and way of operation in biological systems. The first three-dimensional 
structure of protein, the structure of myoglobin, was determined with use of X-ray 
crystallography by John Kendrew in 1958 (Kendrew et al. 1958). Since then it is 
continuously been the most commonly used method for structure determination of 
macromolecules. In essence, to solve a three dimensional protein structure using X-ray 
diffraction, protein needs to be purified, crystallized and the crystals are subjected to 
diffraction experiment in an intense X-ray beam. A crystal mounted on a goniometer is 
gradually rotated on one axes of the goniometer. Some X-rays are diffracted by the 
electron clouds of crystalline protein atoms resulting in a different two-dimensional 
diffraction pattern for each angle of rotation. The positions of the reflections are 
characteristic of the lattice spacing and symmetry of the crystal, but the intensities of the 
reflections vary based on the contents of the crystal. The three dimensional electron 
density map can be determined by a crystallographer by sophisticated process of finding 
phases by SAD, MAD or MR techniques (Drenth 1999). Assuming that we know the 
polypeptide sequence, in many of the cases model building can be done automatically 
using modern crystallographic software. Crystallographers need to use his/her own 
experience in combination with sophisticated validation tools to complete a series of 
tasks to generate a final model. This includes verifying the correctness of the 
automatically built model, filling in unmodeled fragments of the polypeptide, modelling 
ligands incorporated into the crystal (both intentionally as well as unexpectedly), 
refining stereo-chemical properties of polypeptide bonds, and choosing the most 
probable and best fitting side chain rotamers of amino acids.  
Despite the undeniable advantages, X-ray crystallography is not a trouble free 
method. The main limitation of X-ray crystallography of macromolecules is a 
requirement of diffraction-quality protein crystals. Protein crystallization is a difficult 
process that is different for every protein construct. Small and average-sized globular 
proteins with rigid structure are more likely to crystallize and form well diffracting 
crystals. On the other hand, flexible multi-domain proteins very often fail to produce 
well-ordered crystals. It is common for electron density maps to be absent or difficult to 





Another significant disadvantage of protein crystallization is the need for large 
quantities of the purified protein of interest. This often necessitates the use 
of recombinant proteins and their overexpression outside of the source organism. 
1.2.1 Protein Crystallization 
Protein crystals were studied a long before the discovery of X-rays beams by 
Röntgen in 1895. The first characterized protein crystals were earthworm hemoglobin 
described by Hünefeld in 1840. Those crystals were obtained by dehydration of worm’s 
blood between two slides of glass (Hünefeld 1840). The same rationale, slow 
evaporation of a concentrated protein solution that becomes supersaturated and induces 
nucleation is a foundation for many current protein crystallization techniques. Until the 
late 1930s when the first X-ray diffraction images of hemoglobin and chymotrypsin 
crystals were recorded (Bernal 1938), protein crystallization was used mainly for 
purification purposes (Luft et al. 2014). Protein crystallization is a critical step for 
structure determination by X-ray crystallography as only pure, regular and large enough 
crystals can provide a good quality diffraction data that will allow the determination of 
high-resolution model of the molecule. 
Proteins are usually soluble at physiological conditions, but in a supersaturated 
solution, the protein concentration exceeds the solubility limit of the protein, resulting in 
protein precipitation or crystallization. Addition of salt or organic solvents to protein 
solution can result in precipitation caused by high ionic strength (Drenth 1999). The 
process of protein precipitation in solution of high ionic strength is called salting out. 
Protein crystals arise by a repeatable association of protein molecules that interconnect 
by non-native intermolecular, predominantly hydrophilic, interactions called crystal 
contacts. Native contacts between protein molecules are referred as biological contacts 
or oligomeric contacts and usually involve larger surface area with hydrophobic patches 
(Dasgupta et al. 1997).  
There are three common stages during the crystal formation process for both 
macromolecules and small molecules. These stages are nucleation, crystal growth, and 
cessation of growth. First two stages occur in supersaturated solutions. Crystal 
formation begins with the nucleation stage when some critical amount of molecules 





growth is caused by decrease of concentration of free molecules in solution or by build-
up of impurities on crystal faces (Russo Krauss et al. 2013).  
Solvent is an intrinsic and very important part of protein structure. In contrast to 
small molecule crystals, protein crystals have high solvent content, in the range of 40 to 
60% for most of the cases or 20 to 80% in extreme cases (Trillo-Muyo et al. 2013). This 
feature causes protein crystals to be very fragile and sensitive to dehydration. Crystal 
spaces lined with ordered water molecules are called channels (Frey 1994). In addition 
to ordered solvent molecules, spaces of protein crystal that are filled by unordered water 
molecules are called cavities. Polar amino acid residues exposed at protein surfaces 
interact with water molecules, ions and other molecules dissolved in the solvent solution 
creating the hydration shell of the protein molecule. The hydration shell is mediated by 
hydrogen and electrostatic bond interactions with neighboring protein molecules 
(Salemme 1988). Additionally, nonspecific interactions like van der Waals and 
hydrophobic interactions are also involved in formation of protein-protein contacts. 
Protein crystallizability and the contribution of specific and nonspecific interactions in 
crystal contacts varies between proteins and it is dependent on many factors including 
the identity of the precipitant and its concentration, protein concentration, additives, 
temperature, buffer identity, crystallization technique, pressure, detergent, magnetic and 
electric fields, but most importantly pH and the ionic strength (Salemme 1988; Kierzek 
and Zielenkiewicz 2001; Russo Krauss et al. 2013). 
Proteins are large, flexible, and dynamic molecules. Therefore, protein crystals 
are sensitive to dehydration, change in temperature, pH, or ionic strength. Change in 
any of these parameters may affect crystal growth. Because proteins are much larger 
than small molecules, unit cells of protein crystals are bigger and crystals grow slower. 
Moreover, protein crystals are also smaller and less well ordered. Unfortunately, 
nowadays protein crystallization is still a process of trial and error. 
1.2.2 Diffraction 
Diffraction from a three-dimensional periodic structure such as atoms in a 
crystal is called Bragg diffraction in honor of William Lawrence Bragg and his father 
Sir William Henry Bragg, who explained this phenomenon (Bragg 1913). Bragg found 





scattered by parallel crystal planes. The angle of scattered beam is equal to the angle of 
the incidence beam. If the difference in the path-length of the scattered beam is equal to 
integer number of wavelengths, then the scattered beam will be subjected to 
constructive interference (Figure 3). Bragg explained this phenomenon with an 
equation, which is commonly known as Bragg’s law: 
nλ = 2dsinθ, 
λ is the X-ray wavelength (where λ ≤ 2d), d is the distance between crystal planes, θ is 
the angle between the incident beam and crystal plane, n is the order of the diffracted 
beam (integer number). 
 
Figure 3 Constructive interference of X-ray waves explained by Bragg’s law. 
1.2.3 Phase problem 
The electron density in a crystal at any position (xyz) can be obtained by 
calculating the Fourier summation: ρ(xyz) = 1/V ∑ |Fhkl| exp(ihkl)exp(−2πihx+ky+lz), 
where hkl are measured intensities, V is the volume of the unit cell, and hkl is the phase 
corresponding to the structure-factor amplitude |Fhkl| (Taylor 2003). In an X-ray 





detector. The amplitude of the wave is proportional to the square root of the intensity, 
but information about its phase is lost. In macromolecular X-ray crystallography, three 
approaches are used for recovering the phases: 
 isomorphous replacement (SIR / MIR) is recovering phasing information with use of 
heavy-atoms derivatives of isomorphous crystals, 
 anomalous diffraction (SAD / MAD) is based on the presence of sufficiently strong 
anomalous scattering atoms within the protein crystal, 
 molecular replacement (MR) is utilizing phases obtained for the homologous protein 
or the same protein in a non-isomorphic crystal. 
1.2.3.1 Isomorphous replacement (SIR/MIR) 
Isomorphous replacement is a method for the phase determination based on 
determination of the contribution of a heavy atom derivative to structure factors of the 
sample. Diffraction data for the native and isomorphous, heavy atom soaked crystals are 
needed in order to calculate contribution of the heavy-atom to each structure factor. The 
structure factors of heavy-atom derivative crystal are the vector sum of the heavy atom 
structure factor and native crystal structure factors. The contribution of heavy atoms to 
each structure factor can be calculated using the Patterson function or direct methods. 
The method is called single isomorphous replacement (SIR), when a single heavy atom 
is used and multiple isomorphous replacement (MIR), when multiple heavy atoms are 
used (Drenth 1999; Taylor 2003).  
1.2.3.2 Anomalous dispersion (SAD/MAD) 
Friedel’s law says that Bragg reflections related by inversion through the origin 
(i.e., Friedel’s pairs) have equal amplitudes and opposite phase. If the wavelength of the 
X-rays correspond to the energy of transitions between electron shells of the heavy 
atom, it will result in phase modification (Drenth 1999). This phase shift results in 
breaking Friedel’s law and differences between the measured intensities of Friedel pairs. 
The atomic scattering factor is given by f + f' + i f" where f' and f" are the real and 





between these two components. Typically, for SAD/MAD technique, protein 
methionine residues are substituted with selenomethionine residues and the anomalous 
scattering is measured in single crystal. The SAD method uses data collected at the peak 
of anomalous atom diffraction, and the MAD technique additionally uses data collected 
at inflection point and remote wavelength (Taylor 2003). 
1.2.3.3 Molecular Replacement 
Molecular replacement (MR) is an approach to solve the phase problem by using 
a homolog with known structure or even a structure of the same protein in a 
non-isomorphic crystal. Assuming that r.m.s.d between C atoms of the homologous 
model and the target structure is low, a homologous model can be used for calculation 
of the initial phases (Taylor 2003). An initial density map can be obtained for a structure 
using the Patterson function, which discards the phases and using squared amplitudes. 
The principles of this technique were proposed by Rossman and Blow (Rossman 1962). 
The first step is to deduce the number of molecules, their orientation, and accurate 
placement in the target unit cell. Once the MR model is properly oriented and 
positioned in the unit cell, it can be used to calculate the phases, which in combination 
with observed structure factors allow calculation of electron densities, and subsequently 
for building and refinement of the sought structure (Drenth 1999). Structures solved by 
molecular replacement may contain errors due to the possibility of phase bias. Parts of 
the model may be wrong, but the map may not show this.  
1.3 Structural Genomics (SG) 
Structural genomics is a high-throughput (high-output) approach to structural 
biology, a worldwide effort for determination of three-dimensional structures for all 
proteins and other gene products that are encoded by complete genomes (Brenner 
2001). Pilot SG projects started in late ’90s after sequencing of the first complete 
genomes. Initially, mapping of the protein universe (Vitkup et al. 2001) and 
development of high-throughput methods were the primary concerns. The two main 





sequence similarity to proteins of known structure and provide insight into their 
function by recognizing homology between proteins that share the same fold regardless 
of divergent sequences (Brenner and Levitt 2000). Additionally, the novel structures 
were utilized as templates for homology modeling of millions of protein models. This 
approach increased the structural coverage of proteins (including reliable homology 
models) from 30% to 40% (contributing ~50% of the newly characterized families) over 
the last ten years (Khafizov et al. 2014). Despite the development of novel technologies 
and thousands of structures, SG projects were criticized for producing large number 
(i.e., 26% of all structures SG deposited to PDB (Chruszcz et al. 2010)) of structures 
that are missing functional assignment or their function is referred to as putative. 
Therefore, the largest structural genomics project, the Protein Structure Initiative, 
currently named PSI:Biology, shifted its focus to the application of previously 
developed high-throughput structure determination pipelines via highly organized 
networks of investigators to research important biological and biomedical problems 
(SBKB 2015). 
1.3.1 Pilot structural genomics projects 
The era of SG research started in 1995 with the proposal of the first structural 
genomics project in Japan. Two years later the pilot project started at the RIKEN 
institute. The same year in USA, Department of Energy (DOE) and National Institute of 
General Medical Sciences (NIGMS; one of the National Institutes of Health) started the 
initial phase of structural genomics in the United States. The New Jersey Initiative in 
Structural Genomics and Bioinformatics was established. In January 1998, a workshop 
on Structural Genomics was held at Argonne National Laboratory in USA and initial 
pilot projects started in Germany, Canada, and USA. In October of 1998, the Structure-
Based Functional Genomics meeting took place at Avalon in USA. In June 1999, a call 
for grant applications for NIGMS/NIH pilot projects was announced. The year 2000 
was breakthrough year. In January 2000, OECD Committee for Scientific and 
Technological Policy (CSTP) proposes to initiate SG studies. The First International 
Structural Genomics Meeting took place in April in Hinxton, UK. In September, 





November of 2000, First International Conference on Structural Genomics took place in 
Yokohama, Japan (MCSG 2014). 
1.3.2 Protein Structure Initiative (PSI) 
The Protein Structure Initiative (PSI) is the largest ongoing structural biology 
project established in the year 2000 by NIGMS. Nine pilot centers, i.e., Joint Center for 
Structural Genomics (JCSG), Midwest Center for Structural Genomics (MCSG), 
Northeast Structural Genomics Research Consortium (NESGC), New York-Structural 
GenomiX Research Consortium (NYSGXRC), Center for Eukaryotic Structural 
Genomics (CESG), Berkeley Structural Genomics Center (BSGC), Southeast 
Collaboratory for Structural Genomics (SECSG), TB Structural Genomics Consortium 
(TB), and Structural Genomics of Pathogenic Protozoa SGPP were established during 
the initial phase of the project. The first phase was dedicated to development of 
methodology for a subsequent production phase, testing the feasibility of high-
throughput structure determination, and solving unique protein structures (Lee et al. 
2011). During PSI-1, which lasted from October 2000 to June 2005, PSI centers 
produced 1416 protein structures, providing the first structure representatives for 355 
(2.9% of all) PFAM families (SBKB 2011). PSI-2 lasted from July 2005 to June 2010 
and focused on implementing the methods developed in PSI-1, homology modelling and 
addressing bottlenecks, e.g., modelling membrane proteins (Lee et al. 2011). The 
number of research centers was increased to 14 and additionally two resource centers 
were established: the PSI Structural Biology Knowledgebase (SBKB)(Berman et al. 
2007) and PSI Materials Repository (PSI-MR). During PSI-2, 3786 structures were 
solved (SBKB 2011) out of which 561 (4.6% of all PFAM) are the first structural 
representatives of PFAM families. PSI: Biology, the third and the last phase of PSI 
started in July 2010 and is focused on utilizing the high-throughput structure 
determination pipelines to answer broad and challenging biological questions 
(Montelione 2012). The PSI:Biology research network is organized around 4 centers for 
high-throughput structure determination, 9 centers for membrane protein structure 






To date, PSI centers solved ~51.5% (as on 8 January 2015; (RCSB 2015)) of all 
SG structures. PSI researchers developed an impressive number of new technologies, 
including among others auto-induction media (Studier 2005), a wheat germ cell-free 
protein production system (Vinarov et al. 2006), and a whole range of methods for 
improvement of crystallization, i.e., surface entropy reduction (Derewenda and Vekilov 
2006), in situ proteolysis (Dong et al. 2007), large-scale reductive methylation of lysine 
residues (Kim et al. 2008), nanolitre volume crystallization (Gerdts et al. 2008). 
Aforementioned methods and many other new vectors, expression systems, and 
experimental protocols decreased time and cost of protein structure determination. PSI 
also influenced computational modeling projects, i.e., Critical Assessment of Structure 
Prediction (Moult 2005) and Critical Assessment of Automated Structure Determination 
by NMR (Rosato et al. 2009) by providing the majority of targets. 
1.3.3 Description of selected centers 
1.3.3.1 Structural Genomics of Infectious Diseases  
The Center for Structural Genomics of Infectious Diseases (CSGID) and Seattle 
Structural Genomics Center for Infectious Disease (SSGCID) are two consortia that 
were established by National Institute of Allergy and Infectious Diseases (NIAID) with 
the common goal of determining three-dimensional structures of proteins from human 
infectious pathogens (Anderson 2009; Myler et al. 2009). Both centers have their own 
state-of-the-art high-throughput gene-to-structure pipelines capable of determining the 
three-dimensional structures of proteins by X-ray crystallography and NMR (Figure 4). 
CSGID and SSGCID accept structure determination requests from the scientific 
community and assign to the requested targets the highest priority. Proposed proteins 
can be drug targets, important enzymes, virulence factors, vaccine candidates, and other 
proteins with biologically important role (Myler et al. 2009). Both centers target 
proteins from organisms classified into categories A-C in the NIAID Pathogen Priority 
List as well as organisms causing emerging and re-emerging diseases, and close 
homologs of those proteins from closely related organisms (Anderson 2009). The 
CSGID organisms of interest include members of Bacilli genus (i.e., Bacillus, Listeria, 





Francisella, Salmonella, Shigella, Vibrio, Yersinia), Clostridia (Clostridium), 
Epsilon-proteobacteria (Campylobacter, Helicobacter), dsDNA viruses (Orthopoxvirus, 
Rhadinovirus, Roseolovirus, Erythrovirus), and ssRNA positive-strand viruses 
(Calicivirdiae,  Alphavirus, Coronavirus, Enterovirus, Flavivirus, Hepacivirus, 
Hepatovirus, Hepevirus) (Anderson 2009). Other organisms from A-C categories in the 
NIAID Pathogen Priority List are covered by SSGCID. Targets may include also other 
human pathogens (with the exception of human immunodeficiency virus) and their 
phylogenetically related organisms. All structures produced by the consortia are 
submitted to the Protein Data Bank (PDB), and all materials (clones and protein) 
generated are publicly available.  Experimental procedures and weekly target status 
reports are submitted to the TargetTrack database. The CSGID and SSGCID 
experimental results are publicly available through the project websites: 
http://www.csgid.org/ and http://www.ssgcid.org/, respectively. The database 
management system UniTrack that is described in this work was developed 
specifically for the CSGID. 
 
Figure 4 Diagram of the CSGID structure determination workflow. Red arrows indicate the 





1.3.3.2 Midwest Center for Structural Genomics 
The Midwest Center for Structural Genomics (MCSG) is a large-scale SG center 
that was established in the year 2000, during the initial phase of PSI. The main aim of 
MCSG was to increase the structural coverage of protein superfamilies by the efficient 
determination of protein structures using X-ray crystallography and advancement in 
purification, crystallization, data collection, structure solution, and computational 
methods (MCSG 2014). In result, the center produced over 1000 structures during the 
first two phases of PSI (Lee et al. 2011). During the current PSI:Biology phase, MCSG 
is pursuing three scientific programs: proteins associated with virulence in human 
pathogens, proteins overrepresented and associated with disease in human microbiomes 
and proteins involved in signaling and transcription regulation (MCSG 2014). Center is 
organized around seven highly integrated cores: Bioinformatics, Gene Cloning and 
Protein Expression, Eukaryotic and Viral Proteins Expression, Purification and 
Crystallization, Data Collection and Analysis, Structure Determination, and Databases 
and Laboratory Information Management System (LIMS) (MCSG 2014). One of the 
main considerations of MCSG is data dissemination, which is done through peer-
reviewed publications, the PSI-Knowledgebase (PSI:KB), the PSI-Materials Repository 
(PSI MR) and by maintenance of the database of the experiments and connected 
knowledge dissemination portal. Since the beginning of the PSI:Biology phase, MCSG 
is using the UniTrack system for data management. The MCSG data dissemination 
portal and target tracking database are publicly available through the project website, 
http://www.mcsg.org/. 
1.3.3.4 New York Center for Structural Genomics 
The New York Structural Genomics Research Consortium is one of the four 
large-scale SG centers established during the pilot phase of PSI. During that period the 
project was based on collaboration of PSI and industrial laboratories and aimed to 
develop modular technologies that could be utilized in structural biology laboratories in 
both academia and industry (Bonanno et al. 2005). The main achievement of the first 
5 years of NYSGRC was the high-throughput gene to structure pipeline, which to this 





PSI, the project was focused on proteins that share less than 30% identity to any protein 
with known structure. In the current PSI:Biology phase, the project is focused on some 
high-priority targets including multidomain eukaryotic proteins, multi-component 
assemblies, secreted proteins, protein phosphatases with the emphasis on human 
phosphatases, and members of two large protein superfamilies: enolase and 
amidohydrolase (Almo et al. 2007; Pieper et al. 2009; Sampathkumar et al. 2010). To 
meet the challenges introduced by new demanding targets, the NYSGRC structure has 
been reorganized. One of the main changes is a new data management platform based 
on the LabDB LIMS and a specifically adapted UniTrack system. The NYSRGC 
experimental data and protocols can be accessed through its web portal:  
http://kiemlicz.med.virginia.edu/nysgrc/. 
1.3.3.5 Enzyme Function Initiative 
The enzyme Function Initiative was founded by NIGMS with the main goal to 
develop large-scale sequence/structure-based strategy for functional assignment of 
unknown enzymes discovered in genome projects (Gerlt et al. 2011). EFI is not 
structural genomics center, but its multidisciplinary strategy is being developed and put 
into practice by specialized scientific cores, including a protein core, structure core, 
microbiology core, computation core, and data management core. During the first phase 
of the grant, five bridging projects groups focused on large and functionally diverse 
protein superfamilies, i.e., amidohydrolases, enolases, glutathione transferases haloacid 
dehalogenases, and isoprenoid synthases. Each of these superfamilies contains at least 
10,000 members. After the first three and half years the research focus was changed to 
functional discovery in solute binding protein components of transport systems and 
novel pathways unique for human gut microbiota (Gerlt 2014). The EFI’s data 
management core was established to distribute experimental results to community and 
most importantly to create data management infrastructure. The data management 
platform that is used by EFI is based on the LabDB LIMS and UniTrack system. 






1.4 Importance of data management for SG projects 
These days when life-sciences research is frequently done by large scale and 
highly automated scientific organizations, databases and specialized computer software 
are a prerequisite for efficient experimental data analysis. Design and effective usage of 
such tools is not an easy task and requires a deep understating of handled data by 
computer programmers and close cooperation with users during software design and 
development. The size, complexity, and heterogeneity of data are constantly growing, 
which makes data management more and more challenging. Structural biology is not an 
exception from that rule. A single protein project may require many repetitions of the 
various steps due to difficulties at different levels of the structure determination 
pipeline. High-throughput techniques are becoming more accessible and even traditional 
laboratories use crystallization robots that perform large amounts of crystallization trials 
(Prilusky et al. 2005). Experimental observations may be additionally used for data 
mining studies that would benefit the success rate of protein production and structure 
determination experiments. Some of the SG consortia, including Northeast Structural 
Genomics Consortium (NESGC) and Joint Center for Structural Genomics (JCSG), 
successfully applied aforementioned approach. NESGC developed a decision tree 
algorithm for prediction of the protein solubility (Bertone et al. 2001) and JCSG 
identified features that correlate with protein crystallization and combined them into 
single score referred to as ‘crystallization feasibility’ (Slabinski et al. 2007). 
The data management issues in SG were raised for the first time at the OECD 
Global Science Forum Workshop on Structural Genomics that was held in Florence in 
June 2000 (OECD 2000). Scientific delegates of OECD member countries identified 
three main issues as particularly important for the structural biology projects. In the first 
place, the delegates pinpointed the need for a stable and permanent funding of databases 
and for development of bioinformatics tools. Next, they emphasized the necessity to 
store structural and functional data in publically available data banks. This is also 
applicable to protocols for cloning, expression, crystallization, and structure 
determination. Finally, the need for better sharing of structural work between 
laboratories distributed worldwide was highlighted. The delegates established that it is 





a small amount of overlap is beneficial for improving the quality of protein structures 
(OECD 2000). 
The most fundamental roles of data management system, such as documentation, 
organization, and data sharing, can be done with simple tools like spreadsheets or 
notebooks. However, large-scale projects need data management systems that not only 
simply store data, but also provide intuitive, efficient, and secure access to it, allow 
annotation and modification of its content, allow easy sharing of the data with use of 
readable hyperlinks and commonly accepted data formats. Ideally, data should be linked 
to data stored in other databases and repositories. Databases should contain substantial 
amount of metadata giving complete representation of information. Above all, the logic 
and design of such system should impose only minimal changes in work organization 
and current data formats. It should be flexible to adapt to the specific needs of the 
laboratory and have the possibility to add new functionality. The innovative SG projects 
evolve during their lifetime requiring from data management system to be easily 
upgradeable. Finally, a system must be made with main goal to overcome specific needs 
of its users. Systems developed without cooperation with perspective users may be full 
of misconceptions or too complicated to use. 
Data management in high-throughput structural biology is usually concerned at 
two distinct levels: the target tracking level and experiment tracking level (Zimmerman 
et al. 2014). The experiment tracking includes all of the information and metadata that is 
typically collected by LIMS’s and the target tracking level contains processed data, 
annotations, and links to external resources. However, it is an arbitrary classification 
and some of the information is relevant on both levels, in general, a majority of systems 
is structured in similar manner.  
1.4.1 Protein Data Bank 
The Protein Data Bank (PDB) is of greatest importance for data management in 
the field of structural biology. It is a freely and publicly available repository for the 
three-dimensional structures of macromolecules and related information. The PDB was 
founded in 1971 at Brookhaven National Laboratories (BNL) (Bernstein et al. 1977) as 
one of the very first biological data repositories. At the beginning, the data bank 





existence, it has grown to over 108,000 structures solved by X-crystallography, NMR 
and electron microscopy. The repository is currently growing at impressive rate of 
approximately 10,000 structures per year (RCSB 2014) (observation based on data for 
years 2013 and 2014). Since the early 1990s, the majority of scientific journals followed 
by some of funding agencies started to require deposition of structure coordinates to 
PDB for all new structures (Berman et al. 2000), following the guidelines of 
International Union of Crystallography (IUCr). In 1998, the management of the 
repository was handed over to the Research Collaboratory for Structural Bioinformatics 
(RCSB). Five years later, the Worldwide PDB (wwPDB) was established. Since then, 
depositions, data processing and distribution of structural data are carried out in parallel 
by RCSB PDB (USA), PDBe (Europe), and PDBj (Japan) that together maintain the 
single PDB archive (Berman et al. 2003). In 2006 the BMRB (Biological Magnetic 
Resonance Data Bank) group (USA), responsible for maintenance of data produced by 
NMR Spectroscopy, joined the wwPDB (Berman et al. 2007). The PDB archive consists 
of flat files, which are distributed via HTTP and FTP protocols, and each member of the 
wwPDB provides own view of the data. Model coordinates are distributed in three 
formats: mmCIF, PDB, and PDBML. PDB is not only repository of 3D structures of 
macromolecules, but each file with coordinates also contains a description of structure 
determination experiments and their results. The X-ray diffraction data files contain 
structure factors - the intensity and phase of the X-ray spots in the diffraction pattern 
from the structure determination experiment (Berman et al. 2007). 
1.4.2 PSI-Nature Structural Biology Knowledgebase 
One of the most important outcomes of the second phase of PSI was 
development of a freely available knowledgebase and data dissemination center called 
PSI-SBKB. The PSI-SBKB web portal is made in collaboration with Nature Publishing 
Group (NPG) (Berman et al. 2009). The knowledgebase is centered on the Target Track, 
a registration database that is monitoring experimental progress and status of protein 
targets selected for structure determination by PSI and other high-throughput structural 
biology projects. Initially this was done by two separate tools: TargetDB (Chen et al. 
2004) and PepcDB (Kouranov et al. 2006), which were developed for the purpose of a 





experiments, respectively. The knowledgebase is also a host for the homology modeling 
portal, technology portal, and the functional annotation module. In order to promote the 
advances of PSI and structural biology in general, the system is using several data 
dissemination routes. One of them is monthly newsletter prepared in collaboration with 
NPG, which gives the scientific community an insight into the most interesting SG 
research, new methods, and technologies developed by SG consortia. Set of web tools 
implemented in PSI-SBKB allows users to check if a protein of interest is being 
investigated by any of the PSI centers or is one of the protein structure requests. It also 
searches for related proteins, homology models, and protocols related to the expression, 
purification, or crystallization of the protein. Additionally, users can check experimental 
status of protein and availability of DNA clones in PSI:Biology materials repository. 
Access to the data is not restricted and users can search for the protein using its 
sequence, macromolecule name, organism, or database identifier, i.e., PDB, PFam etc. It 
is also possible to filter targets by the experimental progress status, availability of 
materials and protocols used (Berman et al. 2009; Gabanyi et al. 2011). PSI-SBKB 
helps to limit the overlap between SG consortia and monitor their progress. 
Nevertheless, the large-scale SG centers need the data management systems not only for 
the purpose of providing the data to the scientific community but especially to prioritize 
targets, effectively manage the vast amounts of experimental data, keep track of 
experiments, and adjust experimental strategies (e.g., choice of expression vectors, 
sequence truncation, crystallization conditions, structure determination procedures). 
These needs require gathering far more data than is required by TargetTrack. 
Consequently, most of the SG centers developed their own more specialized and 
comprehensive data management solutions. 
1.4.3 Xtrack 
One of the first specialized tools for data management in the field of structural 
biology was Xtrack (Harris and Jones 2002). The system consists of a relational 
database with PHP web interface and serves as an electronic notebook that keeps track 
of protein crystallography projects. The idea behind the software is to replace traditional 
lab notebook with more permanent and easier to share web-based alternative. 





is organized around X-ray diffraction dataset, which is referred by the authors as a 
‘collection’. Each collection belongs to higher entity called project. Collection is 
presented on ten separate web pages that contain from 5 to 20 data items and exactly 
correspond to the data structure of the database. Aforementioned pages contain 
information about protein chemistry, expression, crystallization, X-ray data collection, 
data reduction, structure solution, refinement, analysis, and deposition. Useful feature of 
the program is capability to extract data from log files of the most popular 
crystallographic programs, i.e., CNS (Brunger et al. 1998), SCALEPACK (Otwinowski 
and Minor 1997) and REFMAC (Murshudov et al. 2011). Xtrack was not developed to 
handle large-scale projects and it definitely cannot compete with elaborate data 
management systems developed for use of SG consortia, but smaller laboratories will 
appreciate its benefits. It is easy to use and maintain, and it works well for 
documentation of stretched out in time projects and for sharing results with 
collaborators. 
1.4.4 Sesame 
Sesame is a LIMS that was developed specifically for data management in SG 
projects by the Zsolt Zolnai group at the Center for Eukaryotic Structural Genomics 
(CESG). The system is composed from a central relational database and set of web 
based Java applet applications (Zolnai et al. 2003). Sesame, in contrast to traditional 
LIMS, is not build around a single workflow, but it is focused on objects (e.g., protein, 
protocol, and screen) that can be linked freely. Users can adjust the system to their own 
needs by choosing only those modules, which provide functionality relevant to them. 
The main module handles wet-lab as well as NMR, X-ray crystallography, and cryo-EM 
structure determination experiments. Additional modules provide support for target 
requests, lab administration, equipment schedules, metabolomics, crystallization 
conditions browsing, and cryo-EM and NMR screens. Data can be accessed using set of 
views, i.e., ORF, protein, solution, crystal, NMR, small molecule, structure deposition, 
sources (vendors), target submission. Sesame is capable of automatic collection of some 
types of data, e.g., gel scans, NMR, MS, and UV-VIS data (Zolnai 2014). The system 
can generate various reports including a weekly TargetTrack report and output data to 





collaborators to have adequate access to data and modify them. The system is also 
equipped in its own intuitive query system. The authors of the system made it available 
outside of the consortium for individual investigators worldwide. New York 
Consortium on Membrane Protein Structure (NYCOMPS) and Promega Corporation are 
using it, among others. 
1.4.5 HalX  
HalX is another LIMS based system that was developed for handling SG data at 
the Yeast Structural Genomics Laboratory, in collaboration with the European SPINE 
(Structural Proteomics In Europe) project (Prilusky et al. 2005). The system was 
designed specifically for the high-throughput pipeline used by SPINE. It was developed 
in PHP scripting language and uses the PostgreSQL database-management system. 
HalX data model was organized using five categories with database tables that contain 
information about targets, data from public databases, data relevant to all experiments, 
experiment-specific data, and core of the data model. The user interface has six views: 
add experiment, modify experiment, default templates, view experimental results, 
superuser view, and administrators view (Prilusky et al. 2005). Particularly useful 
feature is the ‘default templates’, which allows saving the default protocols and using 
them for faster upload of new records. HalX has a progress page that allows monitoring 
global progress of all targets. Detailed progress for each target is presented in graph of 
linked experiments. Clicking on an experiment box displays its experimental details. 
The system also provides web services for primers design (bestPrimers), choice of the 
most suitable expression system (suggestES), and verification of cloned sequence 
(verifyCloning). HalX is distributed under General Public License (GPL) and can be 
downloaded from http://sourceforge.net/projects/halx/. 
1.4.6 SPINE 
SPINE (Structural Proteomics In the NorthEast) is a LIMS-based data 
management system developed to manage protein production pipeline of the Northeast 
Structural Genomics Consortium (Bertone et al. 2001). The system is a target tracking 





data mining features. Moreover, the database content was used as a training set for 
classification of soluble proteins using machine-learning approach (i.e., decision trees) 
(Bertone et al. 2001). SPINE is using a MySQL relational database and web interface 
written in PERL programming language. The SPINE data model (Bertone et al. 2001; 
Goh et al. 2003) closely mirrors pepcDB data model, with database tables for tracking 
target, construct, expression, purification, biophysical characterization, X-ray and NMR 
data, and protein structure data. SPINE data is associated with many local and external 
resources. Local resources include wiki-based web site, structure gallery, publication 
page, and target information bulletin board (Goh et al. 2003). Several NESG 
computational resources including  SPINS NMR archival database at Rutgers 
University, Proteus crystallization database at Columbia University, PartsList and Gene 
Census databases at Yale University, and University of Toronto LIMS are also 
connected to SPINE (Goh et al. 2003). The web interface consists of several tools: 
SpineSearch, SpineStatus, SpineScoreboard, SpineStructuralGalleries, and SpineAlert 
(Albeck et al. 2006). Data for some of the targets were made publically available after 
determining the structure. Unfortunately, publically available information provided by 
SPINE is limited. Currently only experimental status and list of experimental samples 
are accessible from the web portal. 
1.4.7 SPEX Db 
SPEX Db (Structural Proteomics EXperimental Database) is the data 
management system developed for Montreal-Kingston Bacterial Structural Genomics 
Initiative (M-KBSGI). The system was successfully adapted to serve over 10 structural 
genomics projects in Canada. SPEX Db was designed to provide both target tracking 
functionality and LIMS archiving capability. Targets and experiments are accessible 
using search engine that allows filtering by ids, experimental status, or name of the 
experimenter. Navigation over the experimental stages of the structure determination 
pipeline is simplified by introduction of a tree view for a target. The view is a summary 
table, where columns from left to right correspond to subsequent stages of the pipeline. 
Table rows contain links to experimental records, which are colored according to 
experiment status (i.e., in progress, completed, cancelled) and open as new web pages. 





NCBI, InterPro, and other external databases. Addition of new experimental entries is 
done manually with use of web forms. The system has homology tools, which checks if 
any of the targets has homologs in TargetDB or PDB. Users are informed about change 
of the status for homologous targets by email every week. When sequence identity 
between target and any protein deposited in PDB is >25%, work on that target might be 
stopped. Access to the data is controlled by the identification and authority level of a 





The main goal of this work was to determine the atomic structure of 
isochorismate synthase DhbC from B. anthracis and biochemically characterize this 
enzyme. The biochemical characterization should prove the function of DhbC and give 
basis for further investigation on potential inhibitors of chorismate-utilizing enzymes. 
A parallel objective was to develop a set of tools that together with other 
applications developed in Wladek’s Minor laboratory will constitute an innovative data 
management system for the high-throughput structural genomics UniTrack. The tools, 
the target tracking database for CSGID and a corresponding knowledge dissemination 
portal, will:  
i. improve a data workflow and maximize efficiency of the CSGID 
high-throughput structure determination pipeline, 
ii. allow documentation of experimental work and exchange of this information 
between groups involved in the project, 
iii. satisfy specific needs of four groups of users: community requesters, the 
scientific community that is not directly involved in the project, CSGID 
scientists, and an advisory committee, 
iv. connect various resources and tools used within the center and supplement those 
with links to external resources, 
v. allow monitoring of work progress on the particular protein targets,  
vi. allow monitoring of overall progress of the consortium, 
vii. publicly release experimental data including detailed protocols, 
viii. serve as information hub for the infectious disease scientific community, 
ix. provide numerous ad hoc statistics and dashboards for the reports and analysis 






3.1 Laboratory equipment 
Laboratory experiments, i.e., molecular cloning, expression, purification, and 
crystallization experiments were performed using the following equipment: 
Benchtop centrifuge Beckman Coulter, Allegra® X-15R 
Benchtop shaking incubators VWR Scientific, 1575A 
New Brunswick, Innova 4000 
Centrifuge Beckman Coulter, AVANTI J-26XP 
Gel imaging instrument BioRad, Gel Doc™ EZ System 
Fast Protein Liquid 
Chromatography (FPLC) 
systems 
GE Healthcare Life Sciences, ÄKTAprime plus 
GE Healthcare Life Sciences, ÄKTAFPLC 
Incubator Labnet International Inc., Mini Incubator 
Microplate reader BMG LABTECH, PHERAstar FS 
Screen preparation instrument  Emerald BioSystems, Opti Matrix  
Shaking incubator Labnet International Inc., 
211DS Shaking incubator 




Liquid handling robot TTP Labtech LTD, Mosquito HTS 
Ultracentrifuges Beckman Coulter, Optima™ L-80 XP 
Beckman Coulter, Optima™ XL-100K 
UV-Visible spectrophotometer Schimadzu Corp., UV-2450 
UV-Visible spectrophotometer 
(micro-volume) 





3.2 Solutions, buffers and media 
LB broth Research Products International, Miller’s LB Broth 
M9 selenomethionine 
growth medium 
Shanghai Medicilon, M9 SeMET High Yield 
Lysis/Binding buffer 300 mM NaCl, 
50 mM HEPES pH 7.5, 
5% v/v glycerol, 
5 mM imidazole, 
0.5 mM phenylmethylsulfonyl fluoride, 
1 mM benzamidine 
Washing buffer 300 mM NaCl, 
50 mM HEPES pH 7.5, 
5% v/v glycerol, 
30 mM imidazole 
Elution buffer 300 mM NaCl, 
50 mM HEPES pH 7.5, 
5% v/v glycerol, 
250 mM imidazole 
Dialysis/AKTA buffer 300 mM NaCl, 
50 mM HEPES pH 7.5, 
0.5 mM TCEP 
SDS-PAGE sample buffer Novex®, Tris-Glycine SDS Sample Buffer 
SDS-PAGE running buffer Novex®, Tris-Glycine SDS Running Buffer 
SDS-PAGE protein 
standards 
Bio-Rad, Precision Plus Protein™ Unstained 
Standards 
Coomassie stain Bio-Rad, The Bio Safe™ Coomassie 





3.3 Computer equipment 
Computer programming, database development and in silico analyses were 
carried out using the following computer workstations owned by Wladek Minor 
laboratory: 
‘Anula’ - personal workstation 
Operating system Ubuntu 12.04.2 LTS 
Processor Intel® Core™ i7-3770K Processor 
Ram memory 16GB 
Graphics card GeForce GTS 250 
Disk space 2x1.5TB in RAID-1 array 
 
‘Danuska’ – CSGID-DB database server / CSGID web portal server 
Operating system Red Hat Enterprise Linux Server release 5.10 (Tikanga) 
Processor 2xQuad-core (Intel® Xeon® Processor E5430) @ 2.66GHz 
Ram memory 16GB 
Graphics card ATI ES1000 
Disk space 2TB + 12 TB in RAID-1 partitioned through LVM 
 
‘Soroka’ – MetaPDB database server 
Operating system Red Hat Enterprise Linux Server release 5.6 (Tikanga) 
Processor Quad-core Intel® Xeon® Processor 5130 @ 2.00GHz 
Ram memory 8GB 
Graphics card ATI ES1000 






3.4.1 Experimental data processing and analysis 
Gel documentation and 
analysis 
Image Lab (Bio-Rad) 
Gel filtration monitoring  
and analysis 
PrimeView (GE Healthcare 2011) 
Spectrophotometric enzyme 
assay 
MARS Data Analysis (LABTECH 2011) 
Spectrophotometric 
measurements and kinetics 
calculation 
UVProbe (Shimadzu 1998) 
Crystallographic data 
collection, integration and 
structure solution 
HKL-3000 (Minor et al. 2006) 
HKL-3000 is integrated with: 
SHELXC/D/E (Sheldrick 2008),  
MLPHARE (Otwinowski 1991),  
DM (Cowtan and Main 1993; Cowtan and Zhang 
1999),  
ARP/wARP (Perrakis et al. 1999), 
CCP4 (Winn et al. 2011),  
SOLVE, and RESOLVE (Terwilliger 2004) 
Manual model building  
and validation 
COOT  (Emsley and Cowtan 2004) 
Structure refinement REFMAC5 (Murshudov et al. 2011) 
Structure annotation ICM Pro (Abagyan 1994),  
ActiveICM (Raush et al. 2009) 
Structure validation ADIT (Yang et al. 2004), 





Structure visualization PyMOL (Schrödinger 2010) 
Structure similarity search DALI (Holm and Rosenstrom 2010) 
Sequence similarity search PSI-BLAST (Altschul et al. 1997), 
HHpred (Soding 2005; Soding et al. 2005) 
Structure superposition SSM (Krissinel and Henrick 2004) 
Sequence clustering CLANS (Frickey and Lupas 2004) 
3.4.2 Computer programming and database development 
Scripting languages PHP5 (http://www.php.net/), 
Python (http://www.python.org/)  
with following extension packages: 
BioPython (Cock et al. 2009),  










Distributed revision control Git (http://git-scm.com/) 
Interactive tree browser 
used for visualization of 
structure determination 
pipeline 
JavaScript InfoVis Toolkit 
(http://philogb.github.io/infovis/) 






Molecule viewer web applet Jmol (McMahon and Hanson 2008) 
JavaScript toolkits and 
libraries 
Jquery (http://jquery.com/),  
ExplorerCanvas (http://excanvas.sourceforge.net/), 
Scriptaculous (http://script.aculo.us/),  
modalBox (https://code.google.com/p/modalbox/), 





4.1 Experimental methods 
4.1.1 Molecular cloning 
X-ray crystallization studies require large quantities of homogenous protein that 
can only be obtained by overexpression of recombinant protein in an efficient 
expression host. In order to overexpress the protein of interest, its gene has to be 
inserted into a proper expression vector using molecular cloning. Jason Stam from 
CSGID team at J. Craig Venter Institute did the cloning of dhbC gene. Detailed protocol 
for the experiment is available through the CSGID web portal 
(http://csgid.org/csgid/data/protocols/CSG-003_PCR_and_LIC_v002.pdf). The CSGID 
high-throughput cloning pipelines use pMCSG7 as the primary expression vector and 
pMCSG19c, maltose-binding protein (MBP) fusion vector, for a ‘salvage’ strategy for 
proteins that show low solubility when expressed in pMCSG7. The open reading frame 
of dhbC was amplified by polymerase chain reaction from B. anthracis str. Ames 
genomic DNA using the forward 
5-TACTTCCAATCCAATGCGATGAATGAATTTACGGCTGTAAA-3 and reverse 
5-TTATCCACTTCCAATGCTACTTTTCATTAAGTGAACTATC-3 primers. 
The gene was cloned into a pMCSG7 plasmid using ligation independent cloning 
(Aslanidis and Dejong 1990; Haun and Moss 1992). Ligation independent cloning is an 
alternative for a traditional restriction enzyme cloning that is suitable for 
high-throughput applications (Eschenfeldt et al. 2009). The pMCSG7 is a fusion 
expression vector, which encodes N-terminal hexahistidine tag with eight residue spacer 
followed by the tobacco etch virus protease recognition site (shown as underlined), and 
an SspI restriction site (MHHHHHHSSGVDLGTENLYFQ/SNIGSG) (Stols et al. 
2002). This vector also carries a TVMV protease, which allows in vivo his-tag cleavage. 
Sequencing of the vector revealed cloning artifact, i.e., a single point mutation that 






The pMCSG7-dhbC plasmid provided by JCVI was first amplified in a cloning 
host, E. coli XL10-Gold ultracompetent cells (StrataGene). The transformation reaction 
was performed using a 20 L aliquot of competent cells and 1 L of plasmid. For 
control 20 L of cells were transformed with 10 pg of pUC18 control DNA. The 
reactions were incubated on ice for 30 min. Subsequently, each transformation reaction 
was heat-pulsed for 45 s in a 42°C water bath and instantly chilled by incubation on ice 
for 2 min. In the next step, 600 L of LB medium was added to each transformation 
reaction and the reactions were incubated at 37°C for 1 hour with shaking at 225 rpm. 
Following transformation, 60 L samples of the cultures were plated on LB-agar plates 
with 10 µg/ml ampicillin. The plates were incubated at 37°C overnight. On the next day, 
for the purpose of purification, 5ml LB medium was aseptically inoculated with single 
colony picked up from LB-amp-agar plate and incubated for 16 hours at 37°C to OD600 
of ~4.0. The cells were pelleted by centrifugation at 8000 rpm for 3 min at room 
temperature. Plasmid was purified using QIAprep Spin Miniprep Kit (Qiagen) and high 
yield protocol provided with the kit. Purification yielded 40L of 140 ng/L of plasmid 
DNA. The amplified plasmid was transformed into expression host, E. coli 
BL21-CodonPlus (DE3)-RIPL competent cells (StrataGene). The transformation 
reaction was performed using the same protocol as for the XL10-Gold transformation, 
but the LB-agar plates and media contained ampicillin (100 µg/mL) and 
chloramphenicol (25 µg/mL). A glycerol stock of cell culture was made by mixing an 
overnight culture of transformed cells with equal volume of 50% glycerol, freezing, and 
storing at -80°C. 
4.1.3 Expression 
The initial protein expression, purification, and crystallization screening were 
performed by the CSGID group at the University of Toronto. The 100 L of glycerol 
stock of BL21-CodonPlus cells with the pMCSG7-dhbC plasmid was revived in 50 ml 
of M9 SeMET High-Yield growth media containing 100 g/ml of ampicillin, and grown 
with shaking at 37°C overnight. The next day, 4x10 mL of overnight culture was used 





approximately 1.2. Then, protein expression was induced by the addition of 0.4 mM 
isopropyl-β-D-1-thiogalactopyranoside and the cells were grown overnight (~16 hours) 
with shaking at 20.0°C. Selenomethionine (SeMET) media was used to incorporate 
selenium in to the protein to permit the use of the SAD technique to determine unbiased 
crystallographic phases. The total weight of cells was 27.2 g. Harvested cells were 
flash-frozen in liquid nitrogen and stored overnight at -80 °C for more effective cell 
lysis.  
4.1.4 Cell lysis 
Cell disintegration or cell lysis is a process of extraction of intra-cellular 
components, e.g., an overexpressed protein from expression strain of bacteria, using a 
mechanical or chemical method. A combination of freeze-thaw with sonication was 
used for cell lysis of DhbC expression strain because of its high efficiency. Frozen cells 
were thawed in ice-water bath for about 90 min and suspended in 200 mL of lysis buffer 
with 4 EDTA-free protease inhibitor cocktail tablets (Roche, cOmplete). Next, thawed 
cells were dived into 50 mL batches and sonicated. Cells were sonicated on ice for 
10 min with 10 s pulses and 10 s pauses at the maximum power of the ultrasonic 
processor. Sonicated cell lysate was clarified by centrifugation at 35,000 rpm for 45 min 
at 4°C. 
4.1.5 Immobilized metal ion affinity chromatography 
The supernatant of clarified cell lysate was applied to a nickel-charged affinity 
resin at 4°C. Prior to use, the resin was washed with 20x column volume of ddH20 and 
10x column volume of washing buffer at room temperature. Resin with bound 
recombinant protein was washed overnight at 4°C with ~400 ml of washing buffer. The 
purified protein was eluted at a concentration of 7.9 mg/ml using 10 ml of elution 
buffer. The protein concentration was calculated from absorbance at 280 nm measured 





4.1.6 His-tag cleavage 
The hexahistidine tag was cleaved from the protein by the addition of 1 mg of 
recombinant His-tagged TEV protease per 15 mg of eluted protein in the presence of 
EDTA, TCEP and arginine (final concentrations 1 mM, 0.5 mM, and 200 mM 
respectively). Arginine was included in the buffer in order to suppress protein 
aggregation (Tsumoto et al. 2004; Arakawa et al. 2007). The cleavage was performed 
at 4°C overnight and continued during dialysis to cleavage buffer. Cleaved protein was 
separated from TEV protease by running over nickel-chelating resin (Domagalski et al. 
2013). 
4.1.7 Gel filtration chromatography 
The gel filtration chromatography is a type of size exclusion chromatography 
which uses a hydrophilic packing material and an aqueous mobile phase to fractionate 
macromolecules (Lathe and Ruthven 1956). The eluted protein sample was concentrated 
to ~20 mg/ml using 10 kDa centrifugal filter (Amicon
®
 Ultra 15 mL) and run in two 
2 ml batches through the Superdex G200 column on AKTA FPLC workstation. Both gel 
filtration buffer and the protein sample were filtered through 0.22 m membrane before 
application to the column. The gel filtration flow rate was 1 ml/min and the eluted 
protein was separated into 2 ml fractions. The sharp protein peak eluted at about 83 ml 
elution volume (Figure 5). The level of purification was checked using SDS-PAGE gel 
electrophoresis (Figure 7). The homogenous fractions corresponding to the main AKTA 
peak were combined together, concentrated to 16 mg/ml using 10 kDa centrifugal filter, 






Figure 5 Gel filtration chromatography elution profile of DhbC. The elution volume is plotted along 
the horizontal X-axis and absorption at 280 nm is plotted up the vertical y-axis. The red vertical 
markers on x-axis correspond to elution fractions. Red tick marks correspond to fractions collected 
for gel electrophoresis check. 
4.1.8 SDS polyacrylamide gel electrophoresis 
SDS-PAGE was used to check the purity of protein samples (Figure 6), analyze 
fractions eluted from the AKTA FPLC (Figure 7), and check the approximate molecular 
weight of the purified protein. In this technique, the protein is denatured in the presence 
of an anionic detergent, sodium dodecyl sulfate (SDS) which interacts with hydrophobic 
amino acids and coats it with negatively charged sulfate groups.  Due to the uniform 
distribution of negative charges, the proteins migrate in electric field towards the 
positive electrode inside the polyacrylamide gel (Shapiro et al. 1967; Laemmli 1970). 
The speed of migration, referred as electrophoretic mobility, depends on size, shape, 
and charge of the molecule. Binding of SDS makes proteins charge-to-mass ratio 
proportional to their molecular weight, allowing for fractionation based by approximate 
protein size (Garfin 2003).  
Protein samples were prepared by mixing the protein with Laemmli sample 
buffer in 1:1 ratio, followed by denaturation at 95°C for 5 min and brief centrifugation 
at a speed of 14,000 rpm. Next, samples were separated on pre-cast mini gel 
(NuPAGE® Novex®, 4-12% Tris-glycine protein gel) immersed in Tris-glycine SDS 





foot line of the gel cassette (~ 1 hour). Following electrophoresis, the gels were washed 
3 times with water, stained for 1 hour in coomassie stain with slow agitation, and finally 
slowly washed for 24-48 hours in ultrapure water with slight agitation in order to 
remove the excess stain. The molecular masses of separated polypeptides were 
estimated by comparison of the distance traveled relative to the reference bands of the 
molecular weight protein standard. Finally, gels were documented using a gel imaging 
instrument, and subsequently dried out between two cellophane membranes using 
commercial gel drying solution (Novex®, Gel-Dry™). 
 
 
Figure 6 Purification check of DhbC by SDS-PAGE. Lane 1 – protein standards, lane 2 –cell lysate, 
lane 3 – Ni-NTA flow-through, lane 4 – Ni-NTA washing fractions, lane 5 – Ni-NTA eluted DhbC, 







Figure 7 Purity determination by SDS-PAGE of DhbC after purification using fast protein liquid 
chromatography. Lane 1 contains protein markers, lanes 2-14 contain samples of fractions 
corresponding to main FPLC peak. 
4.1.9 Crystallization  
The initial screening of crystallization conditions was done with the Crystal 
Screen HT kit from Hampton Research and using the sitting-drop vapor diffusion 
technique. The Crystal Screen HT is a combination of Hampton Research Crystal 
Screen and Hampton Research Crystal Screen 2 conditions. The screen is a sparse 
matrix of 96 trial conditions that is biased and selected from known crystallization 
conditions for macromolecules (Hampton Research 2013). 
The crystallization screen was setup using a Mosquito crystallization robot on 
96-well, 2-drop-chamber MRC crystallization plate (Swissci, MRC 2 well 
crystallization plate). The crystallization drops were formed by mixing 400 nL of 
protein with 400 nL of well solution and equilibrated against 40 L of well solution. 
Drops were examined under a stereo microscope immediately after setting up the screen 
and subsequently once a day for the following two weeks. The crystallization process 
was monitored and documented using the Xtaldb database system (Zimmerman 2005). 
The initial protein crystals were observed in the D3 well (100 mM HEPES sodium, 2% 





detected in the initial screen, the crystallization conditions were further optimized using 
the hanging-drop vapor diffusion method. The crystals of 
selenomethionine-incorporated DhbC used for data collection were grown by hanging 
drop vapor diffusion method. The well solution consisted of 2M ammonium sulphate, 
2% v/v PEG400, 100 mM HEPES pH 7.5. Drops were formed by mixing 2 μL of well 
solution and 2 μL of 16 mg/mL protein in 300 mM NaCl, 10 mM HEPES pH 7.5, 0.5 
mM TCEP. Crystals were grown at room temperature and formed after a week of 
incubation. Immediately after harvesting, the crystals were transferred into 
cryoprotectant solution containing 7 % glycerol, 7% sucrose, and 7% ethylene glycol in 
mother liquor, passed through paratone oil and flash cooled in liquid nitrogen. 
 
Figure 8 Octahedron shaped crystals of isochorismate synthase DhbC from B. anthracis. 
4.1.10 X-ray data collection and processing 
Diffraction data for the DhbC crystals were collected at 100K at the 19-ID 
undulator beamline of the Structural Biology Center (Rosenbaum et al. 2006) at the 





which is controlled by HKL-3000 (Otwinowski and Minor 1997; Minor et al. 2006). 
The beamline was operating with standard working energy of 12.660 keV, which 
corresponds to a wavelength of 0.979 Å, i.e., the K absorption edge of selenium. 
The 19-ID end station is equipped in ADSC Quantum 315R CCD detector, which was 
placed at the distance of 300 mm from crystal, resulting in the diffraction limit of 
~2.05 Å at the detector edge (Figure 9). The detector was operating in 2x2 binning 
mode. In the binning readout mode, single pixels are not read individually, but the 
signal is combined in arrays of four neighboring pixels improving signal to noise ratio. 
The exposure time was set to 1 s and the attenuation factor was set to 2. In total, 180 
still frames were collected with oscillation range of 0.4°. Diffraction data were indexed 
and integrated with HKL-3000. The resolution cutoff for refinement was determined by 
commonly used criterion of signal-to-noise ratio, 〈𝐼 ̅/δ(𝐼 ̅)〉, which should not fall below 
2 for the highest resolution shell. 
 





The unprocessed diffraction images are publicly available and can be obtained 
through the CSGID web portal 
(http://www.csgid.org/csgid/pages/diffraction_images/IDP01205_3os6/). Data 
collection, structure determination, and refinement statistics are summarized in Table 2. 
4.1.11 Structure determination 
The next steps after data reduction are determination of the crystallographic 
phases and model building, a process of construction of a stereochemically accurate 
atomic model that will correspond to experimentally determined electron density map 
(Rupp 2010). The structure of the selenomethionine-substituted protein was determined 
using single-wavelength anomalous diffraction (SAD) phasing, and initial models were 
built with HKL-3000 coupled with ARP/wARP. The crystals belong to the primitive 
cubic space group P213, with unit-cell parameters a,b,c= 201.39 Å. The asymmetric unit 
consists of 2 homodimers and 28 Se atom sites, 7 per each protomer. 
4.1.12 Structure refinement, validation and deposition in PDB 
Structure refinement is an optimization step that involves adjusting the initial 
model coordinates to improve the model’s fit to the experimental determined electron 
density (Figure 10). In essence, it is a process of completing the model and fixing 
positions of misplaced atoms. The structure of isochorismate synthase DhbC was 
refined in restrained mode using REFMAC5. TLS refinement (abbreviation for 
translation, libration, and screw-rotation) is a coarse approximation for the anisotropic 
vibrations of atom that involves dividing the structure is divided into regions of 
different isotropic motions. Four TLS groups were used for refinement, one group for 
each monomer in the asymmetric unit. Water molecules were not included in the TLS 
groups. Non-crystallographic symmetry (NCS) refinement was used for averaging the 
density of symmetrical parts of the asymmetric unit. All four subunits of DhbC 
monomer were restrained in a single NCS group. The molecular modelling program 
COOT was used for visualization of electron-density maps, model completion, real 
space refinement, correction of side-chain rotamer conformations, adding solvent 





were used for structure validation. The coordinates and experimental structure factors 
were deposited to Protein Data Bank (PDB) with accession code 3OS6.  
 
Figure 10 Sample of the 2mFo-DFc electron-density map covering the N-terminal residues of the 
refined DhbC crystal structure. All oxygen and nitrogen atoms are colored in red and blue, 
respectively. Red spheres represent oxygen atoms of water molecules. The map was contoured at 
the 1 level. Image reprinted from an original article (Domagalski et al. 2013) 
4.1.13 Spectrophotometric enzyme activity assay for 
isochorismate synthase and Michaelis-Menten kinetics 
Isochorismate synthase activity and its dependence on Mg
2+
 ions were 
confirmed using enzyme activity assays. The assay monitors formation of isochorismate 
by measuring increase of absorbance at 278 nm (He and Toney 2006). Kinetic assays 
were performed using a PHERAstar FS microplate reader at 30C for 10 min. 
100 μL reaction mixture contained 50 mM HEPES (pH 7.5), 300 mM NaCl, 5 mM 
MgCl2, 10 μg DhbC, and 1 mM chorismic acid. Samples were incubated for at least 
10 min at room temperature prior to addition of chorismate and measurements. The 
absorbance was monitored every 60 s for 10 minutes of the reaction. The average 





determination of kinetic parameters. The concentration of isochorismate was calculated 





(Domagalski et al. 2013).  
Michaelis-Menten kinetic constants were determined by performing the 
aforementioned spectrophotometric assay with 1M of DhbC using a series of substrate 
concentrations ranging from 5M to 1 mM chorismate. Measurements were done in 
three replicates for every substrate concentration. The enzyme was prepared in a 
Bis-Tris pH 6.5, 50 mM NaCl, 5 mM MgCl2 buffer. Spectrophotometric measurements 
were performed in temperature of 25C using Shimadzu UV-2450 UV-Vis 
spectrophotometer and UVProbe software. The reaction was performed in a black-
walled quartz cuvette with 2mm width light slit and 10mm light path. Before the 
measurements, baseline correction was applied to set the background absorbance to zero 
to ensure a good reference point before collecting data. Monochromatic absorbance at 
278 nm was measured for 300 s with a 0.2 s acquisition rate. Kinetic constants were 
calculated using GraphPad Prism software. 
4.2 Theoretical methods 
4.2.1 Relational Databases  
The target tracking database and previously established data mining databases, 
i.e., MetaPDB, and MetaSG were developed using an open-source relational database 
management system (RDBMS) PostgreSQL. The relational model is currently one of 
the most popular logical models of database design. In the relational database model, 
information is divided into small non-redundant entities, which are stored using table 
data structures and predefined relationships that connect tables. Each relationship 
belongs to one of three types: one-to-one, one-to-many, and many-to-many. Varied 
content of the database can be organized using schemas that logically group related 
tables, procedures, and views. Relational database requires very precise conceptual 
design and understanding of data as it is often very difficult to implement major changes 
in logical data model without breaking already defined relationships and constraints. On 
the contrary, a well-designed relational database provides high integrity and efficiently 





databases, object-relational databases and graph databases. The choice of PostgreSQL 
was motivated by a fact that it offers high quality standards, stability, security, and 
reliability, but most importantly, because it is released under a liberal and transparent 
open source license. PostgreSQL RDBMS is scalable and allows formulation of 
complex queries using Structured Query Language (SQL). The system is being 
developed by a vast and active community of developers that provide large number of 
database design and administration tools. Moreover, PostgreSQL offers an interface for 
PHP scripting language and it is fully supported by CakePHP framework, which was 
chosen for development of database application, i.e., CSGID portal. 
4.2.2 Web application development 
The CSGID data dissemination portal was developed using an open-source web 
application framework CakePHP (http://cakephp.org/). The framework adapts the 
model-view-controller (MVC) architectural pattern (Figure 11) and it is implemented in 
PHP5 (http://www.php.net/) scripting language. The concept of the MVC architecture is 
based on three separate and overlaying data abstraction layers. The base and largest 
component is the model layer, which is directly interacting with the data. Model is 
responsible for technology independent interactions between objects, i.e., business 
logic. The view layer handles the actual output of the application and generates forms 
that allow for user interaction. The controller is the intermediate part that interacts with 
both model and view layers, handling all of the application logic. The MVC design 
assures clear separation of the business logic from the application services and the 
actual data representation. The complex architecture of MVC framework allows 
development of very large applications without loss of flexibility. Development in 
CakePHP is fast and structured. The framework has a large amount of built-in 
functionality including database access plugins, request handling, web page caching, 
form validation, authentication components, user sessions, and wide range of security 
methods. All this components are utilized by CSGID portal and portals of other SG 
centers managed by UniTrack. The CakePHP community has developed extensive 
documentation and useful practice guides. Use of this software is regulated by 





The application models, controllers, and helper components were implemented 
using the PHP scripting language. The application views are a mix of PHP and HTML. 
The interactive content of the portal was implemented using JavaScript language. The 




Figure 11 Simplistic diagram of CakePHP model-view-controller architectural pattern. 
 
4.2.3 Computer programming 
The CSGID web portal was developed using PHP interpreted language 
(http://www.php.net/). Proposed protein target validation scripts were written using 
Python interpreted language (http://www.python.org/) with BioPython (Cock et al. 
2009), NumPy and SciPy (http://www.scipy.org/) packages. Python was chosen because 
of the availability of advanced libraries for biological and scientific computation. 
Development of the CSGID portal was assisted by using the distributed version control 
system Git. For all of the software development activities, eclipse integrated 





4.2.4 Graphs and visualizations  
Statistics on the CSGID web portal were visualized with use of the Google 
Charts JavaScript libraries. The experimental pipeline was visualized using JavaScript 
InfoVis Toolkit. The dynamic content of the CSGID web portal (i.e., pull down menus, 
calendars, and other) was implemented using Jquery, ExplorerCanvas, Scriptaculous , 
modalBox, JavaScript InfoVis Toolkit and JSCalendar  java script toolkits and libraries. 
Virtual screening results were presented using Jmol: an open-source Java viewer for 
chemical structures in 3D. Electronic structure descriptions were generated using the 
ICM Browser Pro and ActiveICM technology from Molsoft L.L.C. 
4.2.5 Bioinformatics analyses 
Sequence-based homology searches were conducted with PSI-BLAST (Altschul 
et al. 1997). Structure-based homology searches were performed with HHpred (Soding 
2005; Soding et al. 2005) and DALI (Holm and Rosenstrom 2010). Three-dimensional 





5.1 The data management system for Center for 
Structural Genomics of Infectious Diseases 
The CSGID data-management system was developed to serve as a 
multifunctional tool for monitoring of the progression of protein targets through the 
high-throughput crystallographic pipeline by documenting the results of the various 
experiments. The starting point was a system developed for over 7 years for MCSG 
structural genomics center. In CSGID, a protein is often purified at one site, shipped to 
another for crystallization screening, and then sent to a third site for structure 
determination. The unified system keeps track of the location of the samples and 
collects information about target simultaneously from multiple sources. The database 
not only contains information about all of the protein samples, but also expression 
constructs, crystallization drops, crystals, and diffraction datasets. The public view of 
the experimental pipeline is focused on the status and composition of the experiments, 
while some metadata is part of the ‘super-LIMS’ system, LabDB. The central part of the 
system is a hub database referred as CSGID-DB (Figure 12). The database was created 
to store the details of all cloning, expression, purification, and structure determination 
experiments, as well as the results of in vivo and in vitro analyses as they become 
publicly available. It means that for great majority of the protein targets, data is 
available on the day of the experiment. The information is presented in a dynamic, 
interactive format to allow one for quick browsing through all experimental data. The 
database content is accessible through the publically accessible CSGID web portal 
(http://www.csgid.org/). In addition to the information about protein targets and 
experiments for structure determination, the CSGID portal contains results of virtual 
screening and annotations in Molsoft’s ICM format that were automatically generated 
for selected protein targets. Other important features of the portal are that it serves as a 
repository of diffraction images, provides an interactive view of a clustering of the 
isochorismatase-like hydrolases family, and contains a section of customizable statistics 





including CheckMyMetal (CMM) tool for validation of metal-binding sites (Zheng et al. 
2014).  
5.1.1 Central role of the target tracking database in the SG 
data management system UniTrack 
The target tracking database (CSGID-DB) plays a central tracking role in the SG 
data management system UniTrack (Zimmerman et al. 2014) developed in Wladek 
Minor’s laboratory at the University of Virginia. UniTrack is a system that was 
developed specifically for CSGID with use of some tools developed previously during 
many years of data management in MCSG. After two years of successful development, 
variants of the system were applied to three other consortia: MCSG, NYSGRC, and 
EFI. The target tracking database architecture and set of related support databases and 
applications is common for the four centers, but the web portals are highly customized 
for the needs of the particular consortium. Experimental data are incorporated into 
CSGID-DB using XML files in a predefined format. LIMSs used in participating 
laboratories regularly update the XML files with complete information about new 
experiments. On the CSGID-DB side, database update scripts check for changes in 
those files every 24 hours. Alternatively, LabDB (Zimmerman et al. 2014), a LIMS 
developed at University of Virginia, communicates with the CSGID-DB via a 
synchronizing script, which transfers data even more efficiently. The latter approach is a 






Figure 12 Structure of the SG data management system UniTrack. Publically available data is 
marked with blue color and internal data is marked with green color. The red line marks the scope 
of the work described in the thesis. 
5.1.2 Relational schema of the database 
The target tracking database was designed in a modular way with use of many 
schemas that allow easy and clear separation of its content. This design allowed 
adaptation of the database to other SG projects. The CSGID-DB contains following 
schemas: csgid, experiments, users (Figure 13), uniprot, tigr, targets, taxonomy, 
synchrotrons, selections, community, drugbank, experiments, homology, hts, ligands, 
mr, metapdb, metasg, ncbi, nmpdr. Schemas of the target tracking database are divided 
into three groups:  
i. ‘Generic SG center’ schemas, i.e., tables common to any SG center, tables are 
the same in all instances with the data being different in each center (e.g., users, 
targets, experiments, and homology). 
ii. ‘Center specific’ schemas, i.e., tables present in single center 
(e.g., csgid.justification_codes, csgid.jcvi_strains). 
iii. ‘Mirrored’ schemas, i.e., independent from any data from the SG center, these 
tables and data will be same in all instances (e.g., ligands, metapdb, metasg, 





The schema ‘csgid.experiments’ is a logical core of the database and represents 
experimental trials of the high-throughput gene-to-structure crystallographic pipeline. 
The experimental pipeline was divided into 10 stages: 
i. (Protein) Target corresponds to the protein from the list of approved CSGID 
targets. This entity contains information about its gene and common names, 
protein and DNA sequences, experimental stage, external database identifiers, 
NCBI annotations, taxonomy, selection phase, justification, and approval date. 
ii. Clone corresponds to a molecular cloning experiment and contains information 
about expression vector, sequence, primers, mutations, experimenter, protocol, 
status, and date of the experiment.  
iii. Expression refers to protein overexpression, expression organism and its strain, 
media, experimenter’s name, status, and date of the experiment. 
iv. Purification is an entity that corresponds to a purified protein sample, 
v. Crystallization Drop is a single crystallization trial (a standard screening 
experiment results in 96 records). 
vi. Crystal harvest is a crystal that was harvested with diffraction loop, cryo-frozen, 
labeled and sent for an X-ray diffraction experiment. 
vii. Datasets is a set of diffraction images collected from a crystal. 
viii. Structure solution represents processing of the data set. The same dataset can be 
reprocessed multiple times (e.g., failed attempts with difficult data). 
ix. Structure contains final statistics for the model deposited to PDB. 
x. Deposit contains information deposition of a final model to PDB, i.e., PDB 







Figure 13 Fragment of entity-relationship diagram for schema ‘users’. 
5.1.3 Protein target validation 
Before experimental work starts, a new protein target has to pass a validation 
procedure connected with preceding incorporation of annotations from external 
databases such as NCBI GenBank (Benson et al. 2013), UniProt (Apweiler et al. 2004), 
PDB (Bernstein et al. 1977), and the PSI-SBKB (Gabanyi et al. 2011). The validation 
procedure includes a check of the accuracy of the amino acid and the nucleotide 
sequences as well as checking if the selected protein does not have homologs with 
known structure in PDB or among targets already selected by other SG centers. Usually 
targets are uploaded into the database in large batches of proteins that were proposed 





organism. The target validation program was written in the Python programming 
language with use of BioPython modules and FASTA program. The database update 
process is done in three discrete stages: 
i. File with a batch of accepted targets in a XML, CSV, or TSV format is 
submitted from a selection person to a database administrator. In CSGID, targets are 
obtained from UCL target selection database.  
ii. A database administrator runs the validation procedure. First, a submitted file is 
automatically checked for consistency and presence of the obligatory data fields: protein 
database identifier (NCBI Protein ID or UniProt ID), protein sequence, and NCBI 
taxonomy identifier. Next, annotations are downloaded from NCBI or UniProt. Finally, 
raw data, external annotations, and annotated target record are saved into separate tables 
in the database. A script executes a set of predefined checks and updates validation flags 
for the annotated record. 
iii. Targets that pass all of validation checks get CSGID identifiers. Next, 
corresponding records are saved to the ‘protein_target’ table and new targets are 
activated by setting experimental status to ‘selected’. If any targets fail the validation, 
database administrators identifies the problem and reports it to the person responsible 
for target selection. 
Validation checks for new protein targets include (in the order of execution): 
i. Check of sequence coverage between the translation of a nucleotide sequence 
and the amino acid sequence. 
ii. Check of sequence coverage between the amino acid sequence and the sequence 
reported in NCBI or another reference database. 
iii. Check if any of the reference identifiers (i.e., GI number, NCBI accession 
number, or UniProt ID) is already present in the target database. 
iv. Check if the amino acid sequence does not duplicate sequence for an existing 
target, however, duplication of amino acid sequence is allowed if the nucleotide 
sequence is different from nucleotide sequence of the existing target. 
v. Check if the amino acid sequence does not duplicate any target in a related SG 
center (i.e., NYSGRC-EFI, or MCSG-CSGID). 
vi. Check if the protein target does not have any homologs in PDB, which share 





5.1.4 Import of experimental data to CSGID-DB 
The fundamental mechanism for transferring experiment data from the 
participating laboratories into the CSGID-DB is by use of XML files, which are 
published regularly on each site laboratory’s web (httpd) or ftp server. The XML files 
are generated automatically by specifically adapted LIMS that gather data from 
connected laboratory equipment. Nevertheless, responsible scientists are required to 
manually upload scaling log file (Figure 14) and structure coordinates in PDB format 
with short structure annotation when their target reaches the dataset and structure stages 
respectively. They can also add or edit information for other experiments using a set of 
web forms, which are accessible to logged in and privileged users using links in user 
menu and corresponding experiment views. First authors of PDB deposit are also 
obligated to upload diffraction images to the CSGID web portal when their structure is 
released by the PDB. If needed proceeding experimental steps can be also updated 
manually by privileged users. Thus, data are primarily transferred automatically, but are 
also curated by responsible scientists.  
All experiment records must contain an element or a combination of elements 
that can serve as unique identifier of the record (i.e., a primary key). Some elements act 
as foreign keys, which reference records in other XML files as well as relevant 
protocols, expression vectors, responsible person, or laboratory. These foreign key 
identifiers must be consistent, referring to existing records in other XML files. Some 
elements are required and cannot be left empty. Each night a Cron script at the 
CSGID-DB site first downloads XML files (one file for each type of experiment) from 
site laboratories and compares them with current files. If there are changes, Cron runs 
an appropriate PHP script, which updates the database. Scripts process every file that is 
at the same level or below in experimental hierarchy (for clones it updates all, for 
crystal_harvest - only crystal_harvests file). When data is saved to the database, a 
‘SAVED’ flag for a corresponding record in the XML file is changed to ‘YES’. 
Additionally, a nightly mirror of each site’s XML files is copied to an FTP directory of 
the CSGID web portal (ftp://csgid.org/pub/csgid/xml-archive/<site-lab>/). Cron scripts 
send the e-mails to CSGID addresses with a summary report and a list of errors 






The e-mails are delivered to the following people or groups:  
- database administrators (csgid.db@csgid.org) with report summarizing the database 
update and listing encountered errors, 
- the lab that performed the experiment and the database administrators that produced 
the XML file, 
- the responsible laboratory lab, in cases where there was no update in past 2 weeks (e-
mails are sent every week after two-week period without update) 
5.1.5 Communication layer 
The CSGID-DB is a hub database constantly retrieving data from other 
resources and generating reports for other databases. The aforementioned resources may 
be classified into three categories: LIMS, internal supporting databases, and external 
data banks and data repositories. Transfer of the new records between the LabDB LIMS 
and target tracking database is done by the synchronization script written in Python. The 
script is automatically executed every hour ensuring that information about new 
experiment is publically available on the same day. In CSGID, the main update 
mechanism is based on data transfer through XML files (described in paragraph 5.1.4). 
The tracking database employs copies of selected tables from two supporting 
databases: MetaPDB and MetaSG. MetaPDB is a statistical database, which contains 
data parsed from the header section of the PDB files. Additionally, MetaPDB stores 
results of automatic analyses and outputs of many programs, e.g., structure validation 
report from MolProbity or analysis of surfaces, interfaces, and oligomeric assemblies 
from PISA. The data is also manually curated for inconsistencies detected in new PDB 
records. This independent project is a very valuable source of information that was 
utilized for numerous data mining studies. MetaPDB is also used by a variety of 
software and databases that were developed in the laboratory. The CSGID database 
utilizes a copy of multiple MetaPDB tables, which provide data for structure quality 
statistics, information about homologous structures, and metadata about deposition. The 
tables are synchronized weekly, a few hours after the RCSB PDB update. MetaSG is a 





MetaSG table utilized by UniTrack contains details of all PSI targets. This information 
is used for validation of new targets proposals and for statistics.  
 
Figure 14 View of the dataset upload form containing information parsed from IDP01205 





During validation of proposed targets, the target validating script collects 
information from many external resources. The script requires an identifier of at least 
one of the two large protein data banks, i.e., NCBI Protein and UniProt. Information 
parsed from the data banks includes identifiers, DNA and amino acid sequences, 
annotations, GO terms, and taxonomic information. The system also updates the protein 
functional annotations from TIGR. UniTrack generates weekly performance reports for 
TargetTrack, which are available through the CSGID FTP server. The reports include 
updates of experimental status for each target and protocols. 
5.2 CSGID web portal 
The web interface of the CSGID-DB is implemented using the Model–View–
Controller (MVC) architecture, with separate layers for data representation model 
(model), application logic (controller), and web page rendering (view). This modular 
organization allows easier maintenance and development. The web portal was designed 
to fulfill the needs of four groups of users:  
i. Community requesters, researchers from outside of the consortium who submitted a 
request for protein structure determination, 
ii. Scientific community that is interested in the CSGID research, but not directly 
involved in the project, 
iii. Researchers working for the consortium, 
iv. Members of the CSGID advisory committee, who monitor the progress of the 
consortium and provide valuable advice on further strategy development. 
In order to achieve the desired flexibility of the interface, set of roles with 
different access levels were introduced for registered users. Unauthorized users can 
access publically available data, but only registered users assigned to a particular group 
are able to read and modify data belonging to that group. A complete list of predefined 
user roles and their access privileges is presented in Table 1. 
Implementation of the CSGID web portal contains over 50,000 lines of source 
code. The source code was used as a base for development of sibling web portals for 
MCSG, NYSGRC, and EFI. Data management in abovementioned centers is driven by 





Table 1 User roles and access privileges in CSGID web portal.  
 
Admin Staff Crystallographer Lab contact PI VIP 
view own x x x x x x 
view group x x x x x  
view others x x x x x x 
view contact 
only 
x   x x x 
view PI only x    x x 
view VIP only x     x 
edit own x x x x x  
edit group x x x x x  
edit others x  x x x  
edit own profile x x x x x x 
edit group profile x   x x  
edit other profile x    x  
edit admin x      
5.2.1 Target search engine 
A target search engine is an access gateway for information about the CSGID 
protein targets. This tool can be accessed by clicking on ‘target list’ in the top 
navigation menu of the web portal. The view contains a full list of proteins that were 
accepted by the selection committee. Every row on the list contains the CSGID ID, 
priority, stage, locus tag, organism, gene name, protein name and other basic 
information about a target. Each target on that list is highlighted in a color that 
corresponds to its experimental status (Figure 15). The colors range from white, which 
means ‘work stopped’, through multiple shades of gray that correspond to statuses from 
‘selected’ to ‘in crystallization trials’ and four shades of pink that mark the final stages 
from ‘crystallized’ to ‘in PDB’. By clicking on any target on that list, a user is 
redirected to the interactive browser of experiments linked to the project. Users can 
search for protein targets using a wide range of cumulative filters which include: 
selection phase, organism, species, keyword, experimental stage, laboratory (by clone 
location), TIGR category, presence of virtual screening results, focus area, ligand 
studies, functional follow up, and priority. Selection of any of the aforementioned filters 
brings up pull-down menu with a list of possible options. Users can also use CSGID 





the ‘filter columns’ at the bottom of the table, a user can not only decide which targets 
they want to display, but also which information will be reported.  
 






A complete list of over 7000 (7388 as on April 12, 2015), targets is divided into 
many pages, but it is possible to download all the data (or a  filtered list) in CSV or TSV 
formats for use with spreadsheet application, e.g., Microsoft Excel or Open Office Calc. 
The equivalent search views for particular experiments, i.e., clones, expressions, 
purifications, crystallizations, crystal harvests, and datasets, are accessible from the left 
hand navigation menu under link ‘Experiments’. 
5.2.2 Implementation of the crystal structure determination 
pipeline 
The CSGID web portal provides a very intuitive way of navigation through the 
specifics of the experimental process. Each protein target selected from the target search 
engine opens inside an interactive node-link tree browser where the target record is a 
root node and consecutive experiments occupy subsequent child nodes of the diagram 
(Figure 16). Nodes are represented as boxes labeled in an experiment type dependent 
manner. All paths reaching the furthest experimental stage of the tree are highlighted 
with a darker color for easier navigation. While hovering a mouse over any of the tree 
nodes, the most important details of the experiment are shown in balloon pop-up. After 
clicking on that node, information that is more complete appears under the tree. 
Information about each experiment include protocol, experiment date, responsible 
person, information specific for type of experiment, e.g., media type, growth 
temperature, or buffers composition, links to external databases plus researchers’ 
comments. Clicking on some of the identifiers on the page will link directly to other 
databases. This structure is very convenient when one wants to compare different 
cloning, expression, purification, or crystallization trials. The tree not only contains 
successful, but also failed experiments, which can help identify the problems and adapt 
the experimental strategy for targets that are problematic. The system collects up to 400 









Subsequent experiment nodes of the crystallographic pipeline are labelled in the 
following manner: 
i. Protein target: ‘T’ + CSGID identifier 
ii. Clone: ‘C’ + date of the experiment 
iii. Protein expression: ‘E’ + date of the experiment 
iv. Protein purification: ‘P’ + date of the experiment 
v. Crystallization drop: ‘XD’ + crystallization drop identifier 
vi. Crystal harvest: ‘X’+ date of harvest 
vii. Dataset: beamline name 
viii. Structure solution: ‘Sol:’ + phasing method  
ix. Refinement: R-factor 
x. PDB deposit: PDB ID 
 
 
Figure 16 View of the experimental trials for target IDP01205 (B. anthracis DhbC), displayed inside 
the node-link tree browser. Complete experimental details are displayed under the tree after 
clicking on the corresponding node. For easier navigation, the most important details are displayed 
in clouds visible when hovering the mouse pointer over the corresponding box. The longest track on 





5.2.3 Electronic structure description 
One of the key goals of the CSGID is to convert its structural data into useful 
information that can be used by the scientific community. For selected protein structures 
solved as part of the CSGID, interactive 3D presentations are available (Figure 17). 
Slides and animations are generated using ICM software developed by Molsoft LLC. 
Interactive content is embedded directly on the structure description web pages and can 
be accessed after installation of a freely available ActiveICM plugin (Raush et al. 2009). 
Users can rotate and manipulate structures to view structural units, ligands, 
oligomerization states, and B-factor distributions. When available, annotations are also 
provided, giving a functional context to specific structures. Additionally, presentations 
can be downloaded and edited using ICM Browser, Browser Pro, or ICM Pro (Abagyan 
1994). ActiveICM format is being accepted for scientific publishing of enhanced 
versions of articles (Raush et al. 2009) by journals such as PLoS ONE (Qiu and Dhe-
Paganon 2011) and Nature (Li et al. 2011).  
 
Figure 17 Automatically generated electronic structure description for the DhbC structure 
embedded inside the CSGID web portal. 
5.2.4 Homology searches 
In order to limit the efforts overlap within consortium and with other SG 





share more than 80% sequence identity to any structure in PDB or any targets of other 
SG centers. This condition also applies to targets, which are already in the structure 
determination pipeline. When a structure of homologous protein is released by PDB, 
experimental work on the target is stopped unless it is the final stages of the pipeline. 
The CSGID portal contains a tool for the detection of sequence homology. A link to the 
homology search is located on each target page adjacent to protein sequence. The search 
is done on CSGID and PDB sequence databases using the Fasta program (Pearson and 
Lipman 1988). The automated homolog search is run every week by a Crontab script, 
which sends the results by email to all participating laboratories. The script reports all 
active targets that share more than 85% relative sequence identity (as determined by 
FASTA) to any protein deposited in PDB. Targets deposited in PDB, stopped (priority 
0), flagged as ligand studies or functional studies are omitted from this list. The results 
of this search are available in form of XML files, which are located on CSGID FTP 
server. 
5.2.5 Protocols 
Among the many details listed for each experiment accessed through the 
experiment browser, users can find links to complete, detailed protocols used during the 
experiments. The CSGID web portal contains a repository of all of the experimental 
protocols used in the consortium. A complete listing of 72 CSGID protocols can be 
accessed through the following URL: http://csgid.org/protocols/. Protocols are 
categorized according to the experiment type, i.e., selection, cloning, expression, 
purification, crystallization, crystal harvest, NMR and by source laboratory, i.e., ANL, 
Collaborators, JCVI, NIAID, NU, SBI, UCL, UT, UTSMC, UVA, WU. Every protocol 
contains detailed description of the experimental procedure.  
5.2.6 Implementation of virtual screening results 
The CSGID puts a special pressure on determination of protein complexes with 
biologically significant ligands or protein partners. As a part of this approach, Andrew 
Binkowski at the University of Chicago developed a single hierarchical pipeline that 





packages that allow for an exhaustive investigation of protein-ligand interactions. The 
APPLIED (Analysis Pipeline for Protein-Ligand Interactions and Experimental 
Determination) pipeline was designed to predict ligand interactions and provide insights 
on protein function (Binkowski et al. 2014). 
When available, results of the virtual screening are accessible through 
the CSGID web portal (http://csgid.org/screenings/). The virtual screenings web page 
contains table listing all of the experiments and provide information about the docking 
template (e.g., PDB ID, polypeptide chain ID, surface ID), experiment (date, person, 
run ID, compound library used) and results (five of the top hits). A mouse click on any 
row in the table redirects to the experiment view, which contains a table with 1000 
compounds listed in docking rank order and interactive Jmol applet window that 
visualizes binding pocket and docked compounds (Figure 18). The table contains 
information about rank, SMILE code and the ZINC compound identifier linked to the 
ZINC database. Clicking on any row in the table displays the fit of the compound into 
the pocket. User can rotate, zoom and use options available from the Jmol context 
menu, e.g., change representation, display bonds, surface etc. Alternatively, a virtual 
screening results page can also be accessed by clicking on the icon of the protein 
molecule that is displayed on top of target tree browser when the results for particular 
target are available. 
 





5.2.7 Structure gallery 
The structure gallery is a visual presentation of all structures solved by CSGID. 
This view consists of two separate pages for X-ray and NMR structures, which can be 
accessed using the links on the left hand navigation menu of the web portal. Each entry 
contains information about a target ID, deposition details, (i.e., PDB ID, title, authors’ 
names, deposition, and release dates), links to external databases, an image with ribbon 
representation of the 3D structure, and a link to diffraction images, which can be 
downloaded by logged in users. Users can access complete target and deposit records 
using the links on target ID and deposit title. The listing can be sorted and filtered by 
particular organism, selection phase, target, PDB deposit, keyword, or deposition dates. 
5.2.8 Statistics and reports 
The CSGID-DB web portal provides numerous statistics divided into two 
categories: public statistics and performance reports. These are convenient data mining 
tools, and are very important for control of experimental work. A wide range of 
statistics enables researchers to oversee general progress of the project and assess 
bottlenecks. 
5.2.8.1 Public statistics 
The CSGID dissemination portal has a public statistics section, which is 
accessible from the header navigation bar of the website. The statistics section is further 
divided into several overviews that can be switched using the menu on the right side of 
the page. Those overviews focus on the progress of protein production and evaluation of 
the X-ray structure quality. All statistics in this section are generated in real-time and 
some of them can be further adjusted using one of the predefined filters, e.g., by 
(protein) superfamily, species, or organism. The section contains eight dashboards: 
‘summary statistics’, ‘organism distribution: targets and structures’, ‘organism 
distribution: pipeline’, ‘structure statistics’, ‘ligands in deposits’, ‘infectious pathogens’, 





The ‘summary statistics’ page provides the information about the number of 
targets that achieved certain stages of the experimental pipeline. Data is presented using 
a table and column chart. Subsequent stages of the pipeline include: ‘target selected’, 
‘target cloned’, ‘protein expressed’, ‘soluble protein expressed’, ‘protein purified’, 
‘protein crystallized’, ‘diffraction data collected’ (or ‘HSQC obtained’ in the case of 
NMR experiment), and finally ‘submitted to PDB’. Using the pull-down menu on top of 
the page results can be limited to certain organism, species, or selection phase.  
The ‘organism distribution: targets and structures’ page contains two tables and 
two pie charts (Figure 19A), which presents the taxonomic distribution of CSGID 
targets and structures. The data is grouped by organism or species level and can be 
further limited to a particular selection phase. 
The ‘organism distribution: pipeline’ page presents the efficiency of the 
structure determination pipeline for particular organisms. The overview contains a large 
table listing all source organisms and numbers of targets from those organisms that 
reached certain stages in the crystallographic pipeline. An additional last column of the 
table contains the percentage of deposits per clone. The data can be grouped by species 
and filtered by a selection phase. 
The ‘structures statistics’ page is an overview of the structure quality. The 
quality metrics for the deposition of X-ray structures to PDB were discussed on the 
programmatic meeting held between CSGID and SSGCID in November 2008 
(Chicago, IL). At this meeting, researchers defined the ‘refined structure criteria’ that 
need to be fulfilled in order to deposit a structure to PDB. The criteria relate to model 
resolution, R-value and R-free, geometry, completeness, percent of overloads, and I/σ 
value in the high-resolution shell. First two bar charts of the dashboard plot the R and 
R-free distribution in 0.2 Å resolution bins for all CSGID structures (Figure 19B). Two 
scatter plot charts indicate R and R-free values versus resolution for all structures. Two 
other scatter plots represent MolProbity clashscore percentile and MolProbity score 
versus resolution. The last scatter plot shows the number of water molecules per 
polypeptide residue versus resolution for every structure. Dots on all scatter plot charts 
have a color scheme that reflects the structure solution method. All scatter plot charts 
are interactive, a mouse click on any of the chart dots redirects to a corresponding row 
in the table placed below the charts. The table contains target id, information about the 





(resolution, R-value, R-free, MolProbity clashscore percentile, MolProbity score) and a 
link to diffraction data if available. 
 
Figure 19 Selected charts from the CSGID portal public statistics section: The organism 
distribution of all CSGID targets (Fig A) and R-value distribution vs. resolution for all structures 
solved by CSGID (Fig B). 
 
The ‘ligands in deposits’ contains a listing of all ligands identified in CSGID 
structures. Each line describes one ligand and contains information about PDB 
component identifier, name, number of targets and deposits that contain the ligand, and 





relevant), crystallization (crystallization artifacts), and other (i.e., unclassified). Users 
assign the categories when they upload the structure and fill in structure information 
form. 
The ‘infectious pathogens’ dashboard juxtaposes numbers of protein structures 
from selected pathogens solved by CSGID with total number of deposits from these 
species. The presented information includes taxonomic assignment (i.e., classification, 
genus, species), number of PDB deposits before start of the CSGID, current number of 
PDB deposits, number of structures deposited by the CSGID researchers, percentage of 
the CSGID structures among all structures, and percentage of CSGID structures among 
new structures. 
The ‘homologs in PDB’ is a list of all active targets that share more than 85% 
sequence identity with any structure in PDB. Targets are grouped according to their 
most recent location/responsible laboratory. Each line contains information about the 
target (i.e., identifier, experimental status), homologous structure (i.e., PDB identifier, 
chain identifier, deposition date, release date, and name of the last author of 
the deposit), and sequence alignment (i.e., percentage of sequence identity and e-value). 
Members of every research group get information about their pool of targets by an 
automated email. The results omit targets flagged as ligand studies or functional studies.  
In addition to the overviews from the statistics section, the overall advance of 
the experimental work of the CSGID can be monitored using the progress data 
dashboard (Figure 20), which is accessible from the header navigation menu of the 
webpage. The progress page shows the cumulative growth of the number of 
targets/experiments that reached certain stage in the crystallographic pipeline. Growth 
of the number of experiments is measured monthly using the end of the month as a 
cutoff. This chart gives a general idea of how many targets were stuck in one of the four 
major progress bottlenecks of the pipeline, which include production of expressing 







Figure 20 Plot of the cumulative progress for the CSGID center during second phase of the project. 
Four major bottlenecks of the crystallographic pipeline are clearly visible at this dashboard. 
 
Finally, the latest media coverage and awards are displayed in the ‘latest news’ 
box on the main page of the web portal. Users can see all of the previous press releases 
by clicking ‘see all milestones and media coverage’ link above the previously 
mentioned box. The most important structures featured on the NIAID web site in 
section ‘structure of the month’ are also presented there. 
5.2.8.2 Performance reports 
Two of the dashboards serve specifically for generation of performance reports. 
The ‘detailed target report’ is the last overview in the statistics section. This report 
contains short information section for every target, i.e., CSGID target identifier, 
selection phase (project), gene identifier, organism, priority, current experimental status, 
and information about successful and failed experimental trials for every step of the 
crystallographic pipeline (Figure 21). Using a set of filters on top of the page users can 





organism, community collaborator, justification, current experimental stage, and status 
at selected stage of the pipeline. This data can be downloaded in csv format for an 
external analysis in spreadsheet application. This tool was made for generation of 
research performance reports for NIAID. 
 
Figure 21Fragment of the detailed target report dashboard. 
 
The second performance dashboard is restricted to logged in users, i.e., members 
of the consortium. This internal report is accessible from the user menu, which appears 
on top left hand side navigation menu after log in. The internal report page is a set of 
tables summarizing number of experimental trials that were done in each laboratory 
belonging to the consortium. Each table corresponds to different time interval, e.g., 
since beginning of the project, second contract, year by year, or last two months. 







5.3 Structure of isochorismate synthase DhbC from B. 
anthracis 
5.3.1 Overall structure of DhbC 
DhbC crystallized in a primitive cubic space group (P213) with two homodimers 
in the asymmetric unit. In order to obtain unbiased electron density map, the structure 
was solved using a selenomethionine-substituted protein and the single-wavelength 
anomalous diffraction method. Data-collection and refinement parameters are shown in 
Table 2. The single polypeptide chain has 399 residues and molecular mass of 44.6 kDa. 
Due to protein disorder, several fragments were not modeled, including the N-terminal 
8–9 residues, the β6–β7 loop and some residues in the β9–β10 loop (Domagalski et al. 
2013). The structure contains 36 ligands resulting from the crystallization conditions: 
28 sulphate ions, 6 glycerol, and 2 polyethylene glycol molecules. Structural similarity 
searches suggest that DhbC belongs to the aminodeoxychorismate (ADC) synthase 
domain family according to the SCOP classification (SCOP class d.161.1.1) (Murzin et 
al. 1995), Alpha Beta 4-Layer Sandwich according to CATH (CATH class 
3.60.120.10), and the chorismate-binding enzyme family (PF00425) in the Pfam 
classification (Bateman et al. 2004). DhbC adopts the ADC synthase-like fold 
containing four repeats of α–β2–β motif arranged in a four-layer core structure, where 
the layers are α/β/β/α with orthogonally packed β-sheets. The first β-sheet is comprised 
of β6, β2, β1, β9, β10, β19, β20, β8, and β7. The second β-sheet is comprised of β3, β5, 
β4, β17, β18, β11, β12, β16, and β14, and the small third sheet contains β13, β16, and 
β15. The β-sheets are surrounded by nine α-helices (Domagalski et al. 2013). 
The composition of the asymmetric unit, PISA server assemblies analysis (Krissinel and 
Henrick 2007) and the gel filtration results, suggest that a homodimer is the biologically 
functional assembly. The two fold symmetric dimer is made up by joining two β-sheets 
(β3, β5, β4, β17, β18, β11, β12, β16, and β14) into single intermolecular β-sheet. 







Table 2 Data-collection, structure-determination, and refinement statistics for the crystal structure 
of DhbC from B. anthracis (PDB entry 3os6), from. Values in parentheses are for the highest-
resolution shell. Table reprinted from an original article (Domagalski et al. 2013). 
 
 
Figure 22 Overall structure of isochorismate synthase DhbC monomer in cross-eyed ribbon 
representation. The ribbon is colored accordingly to the order of secondary structure elements, i.e., 
from blue at N-terminus to red at C-terminus. Secondary structure elements are labeled and 
numbered. Figure reprinted from an original article (Domagalski et al. 2013). 
Data collection 
    Wavelength (Å) 0.9793 
    Space group P213 
    Unit-cell parameters  a=b=c=201.4Å, α=β=γ= 90° 
    Resolution (Å) 50.00-2.40 (2.44-2.40) 
    No. of unique reflections 105217 
    Completeness (%) 99.40 (100) 
    Redundancy 3.7 (3.7) 
    Mean <I/σ(I)> 20.0 (2.2) 
    Molecules in asymmetric unit 4 
    Matthews coefficient (Å3 Da-1) 3.78 
    Solvent content (%) 67.5 
    Rmerge/Rmeas/Rpim 0.048 (0.532) / 0.054 (0.620) / 
0.026 (0.312) 
Structure refinement 
    Rwork/Rfree 0.171 (0.229) / 0.212 (0.262) 
    No. of residues/protein atoms 1534 / 11630 
    No. of water atoms 763 
Average B factors (Å2) 
    Main chain 42.1 
    Side chains 46.7 
    Overall 44.3 
    Waters 38.4 
Ramachandran plot (%) 
    Most favored 97.9 
    Allowed 2.1 
    Disallowed 0.0 
R.m.s. deviations from ideal values 
    Bond lengths (Å) 0.018 
    Bond angles (°) 1.71 
MolProbity 
    Score 1.36 
    Clashscore 4.39 
    Poor rotamers 1.03% 
Data in the highest resolution shell are given in parentheses 







5.3.2 Comparison of DhbC to other chorismate-utilizing 
proteins with known structures 
Structural searches revealed similarity of DhbC to several isochorismate-binding 
enzymes (Table 3). The closest similarity to DhbC has isochorismate synthase from 
E. coli (Sridharan et al. 2010) as it is shown in Figure 23. EntC is part of biosynthesis 
pathway of the siderophore enterobactin (Sridharan et al. 2010). Enterobactin is a very 
similar to bacillibactin catecholate siderophore with three DHB moieties directly 
attached to a tri-L-serine backbone, whereas in bacillibactin DHB moieties are linked to 
a tri-threonine via glycine spacers. Similarly to B. anthracis and B. subtilis, E. coli also 
has the second isochorismate synthase gene, but EntC is not able to fully restore 
menaquinone deficiency in mutants with a disrupted menF gene (Dahm et al. 1998). 
HHpred analysis showed that salicylate synthetases Irp9 from Y. enterocolitica (Kerbarh 
et al. 2006) and MbtI from M. tuberculosis (Manos-Turvey et al. 2010) as well as 
specific for menaquinone biosynthesis, isochorismate synthases MenF from E. coli 
(Parsons et al. 2008) and Yersinia pestis, anthranilate synthase TrpE from Salmonella 
typhimurium (Morollo and Eck 2001), and 2-amino-2-desoxyisochorismate (ADIC) 
synthase PhzE from Burkholderia sp. (Li 2011) are also structurally similar to DhbC. 
All of the aforementioned proteins belong to ADC synthase structural family according 
to SCOP and take part in conversion of chorismate to isochorismate (EntC, MenF), 















Table 3 The closest B. anthracis DhbC homologs with known structure. Table reprinted from an 
original article (Domagalski et al. 2013). 










isochorismate synthase EntC E. coli 3HWO 38 1.34 354 
salicylate synthetase Irp9 Y. enterocolitica 2FN0 25 1.95 323 
salicylate synthetase Mbtl M. tuberculosis 3LOG 22 1.95 327 
isochorismate synthase MenF E. coli 3BZM 25 1.86 336 
isochorismate synthase MenF Y. pestis 3GSE 22 2.25 324 
anthranilate synthase TrpE S. typhimurium 1I1Q 14 2.30 322 
2-amino-2-desoxyisochorismate 
(ADIC) synthase PhzE 










Figure 23 Superposition of the isochorismate synthase DhbC from B. anthracis and its closest 
homolog isochorismate synthase EntC from E. coli. Figure reprinted from an original article 





5.3.3 Active site 
The active site of B. anthracis DhbC is very similar to the active site of E. coli 
EntC, as shown in Figure 24. Only two of the essential active site residues are different 
between the two proteins: EntC Leu304 is substituted by the chemically similar amino 
acid Val305 in DhbC, while Phe359 is substituted by Tyr360. The second substitution 
should not cause a significant change in enzyme activity, as it is also present in 
B. subtilis DhbC and MenF from both E. coli and Y. pestis. In contrast to EntC, in the 
DhbC structure neither an isochorismate nor a magnesium ion is bound in the active 
site. In EntC, a magnesium ion is coordinated between two glutamic acid residues, 
Glu241 and Glu376, and the C1 carboxylate of isochorismate.  In DhbC, the side chain 
of Glu241 is rotated to the outside of the active site, opening the chorismate-binding 
pocket. The DhbC structure also contains a sulfate ion located in the position 
corresponding to the isochorismate C1 carboxylate in EntC and coordinated by the 
conserved Lys381 and Ser215, and the backbone N atoms of Gly214 and Gly364. 
The arrangement of the enol-pyruvyl holding residues Lys380, Ile346 and Arg347 
(Lys381, Ile347 and Arg348, respectively in DhbC) is not affected by binding of 
isochorismate in the EntC’s active site. The last difference is the orientation of 
stacked pair of aromatic residues. In DhbC, Phe328 and Tyr360 are oriented parallel 
to potential location of the isochorismate ring, which is consistent with the orientation 
of corresponding pairs in structures of other chorismate-binding enzymes. In EntC, 
Phe327 and Phe359 are oriented parallel to pyruvyl group of the isochorismate 
(Domagalski et al. 2013). 
 
Figure 24 Comparison of the active sites of DhbC from B. anthracis and EntC from E. coli. Figure 





5.3.4 Molecular function assignment and Michaelis-Menten 
kinetics 
Isochorismate synthase enzymatic activity of the DhbC was verified using 
spectrophotometric assay that measures formation of isochorismate by following the 
increase in absorbance of monochromatic light at 278 nm. The same type of assay was 
used for recording reaction rates at different substrate concentrations used to calculate 
constants of Michaelis-Menten equation. Formation of isochorismate was observed in a 
reaction mixture containing 10g of enzyme, 1 mM of chorismic acid, and 5 mM 
MgCl2. After 10 minutes reaction time, average conversion rate of 33% (from three 
repeats of the experiment) of substrate was recorded (Figure 25). Conversion of 
chorismate to isochorismate was not detected in two control samples that were missing 
MgCl2 or DhbC. The assay confirmed that DhbC has the enzymatic function of 
isochorismate synthase and that its activity is dependent on the presence of Mg
2+
 ions 
(Domagalski et al. 2013). 
 
 
Figure 25 Results of the enzyme activity assay, which monitors formation of isochorismate by 
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Michaelis-Menten kinetic constants were measured using 1 M enzyme and nine 
substrate concentrations ranging from 5 M to 1 mM. DhbC was found to have 
Km= 164.1 ±21.6 µM and Kcat= 35.4 ±1.61 min
-1
 within 95% confidence interval 
(Figure 26). A substrate velocity curve was fit in with nonlinear regression with 
Rsquared= 0.9918. Kinetic constants of DhbC homologs, E. coli isochorismate synthases 
EntC and MenF were measured previously in several independent studies. MenF was 
found to have Km= 195 ±23 µM and Kcat= 80 min
-1 
as measured with assay that 
monitored absorption at 278nm (Daruwala et al. 1997). In study by Dahm et al. MenF 
was found to have Km= 166.9 µM and Kcat= 144.9 min
-1 
(Dahm et al. 1998). In study 
that used a coupled enzyme assay with isochorismatase EntB, MenF was found to have 
Km= 192 ±7 of and Kcat= 213 ±5min
-1
 (Kolappan et al. 2007). EntC was found to have 
Km= 14 M and Kcat= 173 min
-1 
in study that used coupled assay of EntC with 
isochorismatase EntB (Liu et al. 1990). In more recent study of Sridharan et al. that used 
a coupled enzyme assay with Pseudomonas aeruginosa isochorismate-pyruvate lyase 
(PchB), EntC was found to have Km= 7 ± 0.8 µM and Kcat= 37 min
-1
 (Sridharan et al. 
2010). The large differences in activity between EntC and DhbC may be caused by two-
fold difference in Mg
2+
 concentration, pH, different precision of the enzymatic assay, 
different composition of buffer, or different enzyme preparation. 
 
Figure 26 Nonlinear curve of the DhbC maximum reaction velocity (Vmax) versus the substrate 





6.1 Coordination and documentation of DhbC 
structure determination workflow using UniTrack 
system 
In order to provide more complete information about the B. anthracis 
bacillibactin pathway, the CSGID target selection committee selected four proteins 
encoded by bac biosynthetic operon, i.e., 2,3-dihydro-2,3-dihydroxybenzoate 
dehydrogenase EntA (IDP04314), isochorismate synthase DhbC (IDP01205), 
2,3-dihydroxybenzoate-AMP ligase DhbE (IDP04676), and isochorismatase DhbB 
(IDP04677) for structure determination. Nomination of the aforementioned targets was 
justified by their putative drug target roles and involvement in virulence. Apart from 
members of bacillibactin biosynthetic cluster, multiple other proteins involved in iron 
acquisition in this pathogenic bacterium were selected. The targets belong to following 
groups: iron-binding ABC transporters, i.e., FhuC (IDP04427), FhuD (IDP05715), FatB 
(IDP05050), ferrochelatases, i.e., Hem-H2 (IDP04666) and components of Isd heme 
scavenging system, i.e., S-layer protein (IDP05156), IsdC (IDP05488), IsdJ 
(IDP05417), and IsdK (IDP02799).  
These targets were incorporated into structure determination pipeline through 
standard procedure. First, both internally selected and proposed by community targets 
were reviewed by the CSGID target selection team at University College of London 
using criteria approved by the NIAID. The target selection team assigned a priority from 
0 to 8 to the targets and passed them to a database administrator at University of 
Virginia. The list of targets contains identifiers in public databases, taxonomy 
information, protein and DNA sequences, gene name, justification for selection and 
priority. The database administrator ran the validation tool, which is described in detail 
in the paragraph 5.1.3. After passing all the validation checks, new targets were added 
to the CSGID target tracking database with an initial status and priority set to ‘selected’. 
Since that moment, the database update script regularly checked for new experimental 





(described in detail in the paragraph 5.1.5). All cloning, expression, purification, and 
crystallization experiments were transferred automatically through aforementioned 
mechanism (experimental procedures are described in chapter 4.1). The new records 
were transferred to the tracking database always within one day from appearing in XML 
file. Details of the diffraction experiment, structure solution, and PDB deposit were 
uploaded manually using web forms of the CSGID portal (Figure 14). Finally, the raw 
diffraction images were compressed and published on CSGID FTP server, after 
depositing the final structure in PDB. Diffraction images can be downloaded from 
ftp://danuska.med.virginia.edu/csgid_data/IDP01205_3os6.tar.bz2 (e-mail registration 
at http://csgid.org/pages/diffraction_images is required to get access to the server). 
Detailed history of structure determination experiments for B. anthracis DhbC is 
publically available at http://csgid.org/csgid/space_tree/view/IDP01205 and contains 
hyperlinks to the complete experimental protocols. 
6.2 The purpose of research data preservation and 
public release 
Currently in life sciences, most research is ultimately converted into per 
reviewed articles, which usually contain only a brief description of the experiments. 
Reproducibility of the published results is a common problem (Prinz et al. 2011; Begley 
and Ellis 2012) and may arise from insufficient knowledge about the experimental 
procedure. Additionally, some studies estimate that even 85% of scientific efforts are 
wasted (Ioannidis 2014). Considering the fact that most of the life sciences research is 
funded from public funds, it should be expected that scientists would share all of the 
experimental data and not only the publishable results. In structural biology, publication 
standards are relatively high, as every three-dimensional structure of a macromolecule 
must be deposited to public data bank, i.e., PDB, in order to publish the paper that 
describes it. Moreover, it is a  requirement to release not only the structural coordinates 
of a macromolecule, but also structure factor files that allow other researchers to 
reprocess diffraction data and verify correctness of the protein model. However, the 
information about cloning, purification, crystallization, and sample preparation 
procedure is still limited and their availability depends on the meticulosity of the 





solved by the structural genomics and it is at least partially down to the use of databases 
(Domagalski et al. 2014). Because of the high-throughput nature of the SG workflow, 
only small number of structures solved by SG consortia is converted into peer-review 
papers. Therefore, SG consortia try to make the results available and useful to the 
scientific community in forms other than publications or PDB deposits (Zimmerman et 
al. 2014). The UniTrack system helps to reproduce the results by documentation of 
protocols and detailed specification of the experimental parameters. On every level of 
the structure determination pipeline, a large volume of metadata, including 
temperatures, volumes, dates, and name of the scientist that conducted the experiment 
supplement information. The information is further passed to PSI-SBKB, which 
coordinates progress of all projects within the Protein Structure Initiative. Public release 
of data helps to prevent duplication of scientific efforts. It is particularly important that 
the system release raw experimental data, e.g., unprocessed diffraction images, because 
it will allow their future analysis with more advanced technology potentially leading to 
unanticipated discoveries.  
6.3 Main features of the UniTrack data management 
system 
UniTrack is a target tracking system, functioning as a top data layer that collects 
information from LIMSs used in participating laboratories and other data resources. The 
system consists of the central target tracking database, data dissemination portal, 
supporting databases (i.e., MetaPDB, and MetaSG), LIMS communication layer, and 
target validation script. The LabDB LIMS is used by some instances of the system, and 
its development was not part of this work. The tracking database serves as central 
physical storage for all of the consortium experimental results. The CSGID data 
dissemination portal has been developed as a comprehensive web resource to store the 
data generated by the center as well as to provide both restricted and public access to its 
content. The web interface of the portal allows users to browse the details of 
experiments done on individual protein targets. The set of supporting tools consist of 
auxiliary databases, i.e., annotated database of PDB experimental data – MetaPDB, 





target validation system, experimental data import scripts, report generators, and many 
smaller tools. 
The important feature of UniTrack is its distributed design. The system collects 
all information that is needed for coordination of work on particular targets from 
laboratories distributed in multiple locations. Research groups are both the senders and 
recipients of the information from other groups. Information is broadcasted not by one 
entity, but all research groups simultaneously. The system architecture where one 
central repository integrates data from many distributed sources is named data 
warehouse. The main advantage of such an approach is that the data can be fetched from 
any LIMS without interfering too much with that system. The LIMS systems are 
designed and maintained to meet needs of particular laboratories and changes in their 
architecture should be independent from data handling solutions used outside of the 
laboratory. UniTrack accepts input data in XML files that are relatively easy to prepare 
and does not require any changes on the LIMS side. Thus, each LIMS does not need to 
be exposed to outside of the laboratory, which helps maintain the privacy for some of 
the data. UniTrack has modular design and can be setup up to use different relational 
database management systems or LIMSs. The application provides customized access 
for multiple categories of users, which can be grouped into three main categories: 
researchers involved in project, public community, and advisory committee.  
The main mission of CSGID is to support infectious disease scientific 
community by free of charge determination of important protein structures. Therefore, 
public dissemination of the experimental results is an important functionality of 
UniTrack. Information about protein targets, expression constructs, crystallization 
drops, crystals, and diffraction datasets, and released structures is publically available.  
Details of all experiments in structure determination pipeline for every target are 
accessible using an interactive node-link target browser. The target tracking database 
contains information about thousands of experiments, which may be used in the future 
for data mining studies, e.g., on protein crystallization conditions (based on 
approximately 2.5 million of crystallization trials for almost 60,000 of target proteins in 
four SG centers that use UniTrack). The CSGID portal is also an outreach platform for 
infectious disease community. The website contains structure annotations, ICM 
presentations, numerous links to related sites and external resources, moreover, 






6.4 Comparison of UniTrack with other SG data 
management systems 
Data management in high-throughput structural biology has three 
distinguishable, but partially overlapping levels, i.e., experiment tracking, target 
tracking, and project tracking. LIMSs fulfill the base role of organizing laboratory 
resources and monitoring results of the experiments, those systems are prerequisite for 
every laboratory that does large-scale research. Sesame and HalX are two efficient and 
highly customized for SG research LIMSs. Traditional laboratories often use simpler 
LIMS-type tools, which are commonly called electronic laboratory notebooks (ELNs). 
Xtrack is a lightweight ELN system, which was designed specifically to manage 
collection of X-ray diffraction data. The second level of data management comprises 
functionality related to target selection, tracking experimental progress over targets, data 
dissemination, generation of statistics and reports. Spine, Spex Db, and UniTrack are 
examples of target tracking systems that were developed specifically for SG. The line 
between experiment and target tracking is arbitrary and many of the LIMS systems have 
limited target tracking functionality as well as target tracking systems often have 
features that are typical for LIMS. Nevertheless, classification into experiment or target 
tracking categories gives the best overall description of the system characteristics. On 
top of experiment and target tracking, the PSI-SBKB provides an additional third level 
of data management that aims to monitor progress and synchronize outcomes of all SG 
projects founded within Protein Structure Initiative.  
Certain system features are universal and applicable at every level of the data 
management. Each of aforementioned systems, except the simplest Xtrack, has to some 
extent a modular architecture of its software components. A modular architecture allows 
for relatively straightforward implementation of additional functionality and assembling 
with complementary systems, e.g., UniTrack works with many instances of different 
LIMSs. Likewise, all systems that are used for multi-laboratory collaborative research 
have distributed architecture. Another feature used by all of the systems, except PSI-
SBKB, is role-based access control. Users have different job functions and 
responsibilities, so some operations are assigned to certain roles, e.g., in UniTrack 
access to selected reports is restricted to people with lab contact and PI roles. Users 





users have authorization for editing experimental records if they are members of the 
same laboratory as the author of the experiment. Each SG data management system 
stores some metadata, i.e., information that characterize data. In UniTrack, metadata 
include temperatures, composition and volumes of media, expression strains, protein 
concentrations, type of crystallization plates, dates of experiments, names of the 
experimenters, references to protocols, software, and log files. Finally, all of the 
systems are based on the relational data model, which provides good data integrity and 
consistency, but has lower performance for very large databases.  
UniTrack is very similar to other target tracking systems, i.e., Spex DB and 
SPINE. All three systems have analogous target list pages with search engines that 
allow filtering targets by multiple combined parameters, homology search tools, and 
statistics/report sections. The UniTrack’s “node-link target browser” is the equivalent of 
the Spex’s Db “tree view”. However, in Spex Db experimental pipeline is presented in a 
table form, while in UniTrack analogical pipeline has a form of an interactive graph. 
SPINE and UniTrack web applications also share some similarities, i.e., statistics 
sections, progress summaries, and structure galleries. A unique feature of SPINE is a 
web tools and servers section, i.e., collection of bioinformatics web-tools developed by 
NESG, e.g., primer design, disorder prediction, homology searches, homology 
modeling, structure validation, and functional annotation tools. SPINE has some LIMS 
features, i.e., tracking of target sample tubes and detailed sample histories, however, it 
cannot be considered as a complete LIMS as NESG uses several distributed LIMS-type 
tools, e.g., LIMS dedicated only to crystallization. Unfortunately, public access to 
experimental details of particular targets in SPINE is practically limited to information 
about status and date of the last experiment. On the contrary, UniTrack makes all results 
publicly available at a very detailed level. Other features of UniTrack that make it 
distinctive among target tracking systems are the FTP repository for diffraction images, 
availability of virtual screening results, and automatically generated ICM presentations.  
UniTrack as well as other target tracking systems has workflow-centered design 
based on strictly defined data model, which is an abstraction of high-throughput 
structure determination pipeline used by SG projects. The system is meant to serve 
ad hoc solutions for CSGID and therefore does not have some of the functionalities 
typical for the LIMS system. LIMS-type systems are more flexible and allow defining 
new types of experiments and modifying workflows. Moreover, LIMSs are often 





not have data dissemination features, statistics and progress reports, and contain much 
less annotations than target tracking systems. HalX and Sesame control laboratory 
equipment, store gel images, elution profiles, and pictures of crystals, while in UniTrack 
this functionality was passed to LabDB LIMS system. Nevertheless, UniTrack shares 
some features with experiment tracking systems, e.g., data extraction from log files, 
which is also one of the features of Xtrack.  
Several systems, i.e., UniTrack, Xtrack, Sesame, Spine, and PSI-SBKB allow 
exporting data in CSV or TSV file formats that can be further analyzed in spreadsheet 
program or imported to other database. This feature enables generation of reports or 
statistics, which are not available from the web interface. Comparison of the SG data 
management systems by offered features is presented in Table 4.  
Table 4 Comparison of the SG data management systems features.  





    /    
Target tracking system        
Distributed architecture        
Modular 
architecture        
Flexible workflows/ 
possibility to define new 
types of experiments 
       
Automated data import 
from other resources        
Target validation system 
/ data integration tools        
Search tools        
Open-source 
       
Metadata management        





Data available for 
download (e.g., in CSV, 
TSV, XML, or MS 
EXCEL formats) 
       
Homology search tools        
Access control        




       
Storage of gel images, 
elution profiles, etc. 
*
       
Extraction of 
information from 
diffraction log files 
       
Exchange of data with 
other systems        
Diffraction images 
repository        
Report generation        
Structure annotations         
Statistics / progress 
reports        
* - functionality is available in LabDB. 
6.5 Current use of UniTrack 
The UniTrack is currently used by Center for Structural Genomics of Infectious 
Diseases (http://www.csgid.org), Midwest Center for Structural Genomics 
(http://www.mcsg.org), New York Structural Genomics Consortium 
(http://kiemlicz.med.virginia.edu/nysgrc), and Enzyme Function Initiative 
(http://kiemlicz.med.virginia.edu/efi). Each entity of the system has a common central 
database architecture and set of tools developed for handling targets and experimental 
data. Project portals are based on a template developed for CSGID, which contains 
shared parts like target search browser, tree-view target explorer, statistics section, and 





e.g., virtual screening results explorer in CSGID. UniTrack was designed to 
complement each other with the LabDB LIMS (Zimmerman 2005). The systems serve 
as a complete data management solution for NYSGRC and EFI projects as well as for 
selected groups inside CSGID and MCSG. The view layer of the UniTrack is highly 
customized for the needs of particular center or consortium of research laboratories. The 
total number of database records stored by the system proves it scalability and usability 
for data management of large-scale projects. Considering all four instances of the 
system, UniTrack stores 300 protocols and controls progress of almost 60,000 protein 
targets, 95,000 cloning, 30,000 expressions, 26,000 purifications, 2,600,000 
crystallization trials, and over 4,000 X-ray diffraction experiments, that resulted in more 
than 1,700 structures deposited to PDB. The total number of database records for 
selected experimental categories in four instances of UniTrack is presented in Table 5. 
Table 5 Number of experimental records stored in four instances of the UniTrack (as on 
20/01/2015). For each category, number of targets and number of experiments is displayed.  
 CSGID MCSG NYSGRC EFI total 













































Crystals harvested 690/4,760 605/2,712 345/3,543 215/698 
1,855/ 
11,713 
X-ray diffraction data sets 516/1,733 329/1,238 235/1,259 201/360 
1,281/ 
4,590 
Structures solved 512/826 325/513 218/284 188/284 
1,243/ 
1,907 
Structures deposited to PDB 508/739 319/441 213/261 188/281 1228/1722 
Protocols 72 83 110 34 299 





6.6 Future development prospects for UniTrack 
The UniTrack data management system has proved its ability to facilitate 
high-throughput SG projects. Nevertheless, the SG field is constantly evolving and 
several things can be improved upon in this project. First, there are areas where the 
target tracking database architecture could be optimized, e.g., implementation of 
crystallization experiment. Crystallization experiments are often automated and usually 
done on screening plates containing two or three crystallization drops for every of 96 
different crystallization conditions. In its current implementation, each crystallization 
drop that was setup on the plate is stored in the database as a separate record. The 
excessive amount of crystallization data is particularly burdensome while the complete 
experimental history of a target is being displayed using the tree view browser. 
Crystallization drop records not only slow down the database queries, but also impede 
finding the successful experimental paths on the target tree. The problem was partially 
eliminated by hiding from the tree view browser all crystallization drops that did not 
produce any crystals and by highlighting the most advanced experimental paths with 
darker color. Since most of the crystallization experiments are setup using a limited 
number of commercial sparse matrix sampling kits, introduction of crystallization plate 
template and replacement of crystallization drop entity with a crystal entity would limit 
number of records for all crystallization experiments that use crystallization screens. 
The proposed change would force changes in structure of the XML files used for 
transferring data from LIMSs and therefore it cannot be easily implemented.  
While browsing web interface, users may experience long response times to 
some complex queries, e.g., when accessing real time statistics. In order to limit the 
problem, database queries were optimized, database tables were indexed and 
defragmented, and CakePHP cache was turned on for selected pages. Although 
well-structured SG data naturally fit to relational database model used by UniTrack, 
depending on the speed of database growth and related loss of its performance, upgrade 
to NoSQL database (i.e., graph database, key-value store, or columnar database) might 
be worth considering.  
The other possible improvement specific to CSGID would be implementation of 
infectious disease and protein ontologies to represent the relationship between studied 





relationships among different kinds of entities providing interoperability between 
databases and supporting the annotation and analysis of large-scale data. In the future, it 
will be possible to use them to combine heterogeneous data from different resources, 
and then analyze with systems biology methods towards discovery of relevant 
biomedical patterns. 
One feature that could be introduced to UniTrack that could have the highest 
impact on efficiency improving is automated structure deposition to PDB. 
Unfortunately, in UniTrack’s workflow the final step of the structure determination 
pipeline, i.e., structure deposition to PDB is still manual and time-consuming process. 
In order to deposit a structure in PDB, the responsible crystallographer must solve all 
problems detected by ADIT validation software, convert and check crystallographic 
structure factors, extract information from log files, and fill-up multiple detailed web 
forms. The required information includes contact authors details (i.e., name, e-mail 
address, postal address, phone and fax numbers), a title for the deposited structure and 
any relevant keywords, macromolecule names, sequence and chain ID for each 
macromolecule, including expression tags and residues missing due to disorder, 
information about source organism, expression systems, citation, ligand names and 
chemical diagrams. A large part of this information is stored in target tracking database 
and could be used for generation of annotated PDB file. Additional information stored 
in log files could be retrieved using PDB deposition software. The RCSB PDB already 
tried to automate the deposition process for SG during first phase of PSI, but the final 
goal was never achieved due to many revisions and updates to the PDB format and 
deposition procedure itself. 
The determination of the quality of X-ray structures is still very challenging 
problem. Statistics provided by the UniTrack system are helpful for detecting structures 
that does not fulfill the quality metrics. The CSGID portal is also hosting 
CheckMyMetal server, which enables validation of metal binding sites. Incorporation of 
existing and development of new structure validation tools would be a suitable addition 
to the project.  
A very important aspect of a large-scale project is public outreach. In order to 
accomplish long-term project objectives we need to build the public awareness of the 
scientific problem and promote project achievements. The RCSB PDB provides an 
educational service named PDB 101, which regularly releases short articles about the 





Goodsell). NIAID runs a similar service featuring the most interesting structures of 
CSGID and SSGCID. PSI-SBKB publishes short notes about featured structures and 
articles. The CSGID portal contains a ‘Milestones and Press Coverage’ section that is a 
list of short notes about CSGID structures featuring in press and other services. This 
page can be refactored to regularly present some of the most interesting research with 
more detail, e.g., in the form of extended Molsoft ICM presentations. New updates of 
the page should be spread to the community through an email newsletter. 
6.7 Active site composition and putative catalytic 
mechanism of DhbC 
B. anthracis, similar to closely related B. subtilis and E. coli, contains two 
isochorismate synthase genes dhbC (entC in E. coli) and menF, which are located in the 
biosynthetic operons of catecholate siderophore bacillibactin (enterobactin in E. coli) 
and respiratory chain component menaquinone, respectively. The crystal structure of 
B. anthracis DhbC shows a high degree of similarity, including nearly identical active 
sites, to both E. coli EntC and MenF structures, which have been previously solved. The 
ISC-type active site is also very similar to the active site of the other members of ADC 
synthase-like fold, i.e., anthranilate synthase (AS), 4-amino-4-deoxychorismate 
synthase (ADCS), and salicylate synthase (SS), suggesting that the proteins utilize very 
similar catalytic mechanism to convert chorismate into different products. Analysis of 
the conservation and spatial arrangement of the active site residues combined with 
findings from mutational studies done previously on members of ADC synthase 
superfamily support a putative Mg
2+
-dependent catalytic mechanism originally 
formulated by Walsh and refined by He, Kolappan and other researchers (Walsh et al. 
1987; He et al. 2004; Kolappan et al. 2007; Ziebart et al. 2010). Roles of the essential 
active site residues in DhbC were deduced from the aforementioned analyses. 
According to mutational studies of E. coli EntC (Sridharan et al. 2010) Ala304 
(Ala303 of EntC; Ala344 of E. coli MenF) plays an important role in positioning the 
peptide-bond carbonyl, enabling the formation of a proper hydrogen bond to the 
isochorismate C2 hydroxyl. In EntC, the A303T mutation as well as mutation of the 
neighboring Leu304 (Val305 of DhbC; Val345 of E. coli MenF) to alanine resulted in 





corresponding residues are Ser338 and Met339 in Cytophaga hutchinsonii ADC 
synthase PabB, Ser366 and Ile367 in E. coli ADC synthase PabB, Thr348 and Ala349 in 
Y. enterocolitica salicylate synthase Irp9, and Thr361 and Ala362 in M. tuberculosis 
salicylate synthase Mbtl. In fact, presence of a threonine in the position corresponding 
to EntC’s Ala304 is the only difference between the conserved active site residues of 
salicylate synthases and isochorismate synthases. Strict conservation of the Ala-Val/Leu 
residue pair in DhbC, EntC, and MenF and aforementioned mutational studies in E. coli 
indicate its importance in sustaining isochorismate synthase activity.  
In the EntC structure, a magnesium ion is coordinated by Glu241, Glu373, and 
Glu376 sidechains (Glu241, Glu374, and Glu377 of DhbC), and C1 carboxylate of 
isochorismate. In the structure of DhbC, neither Mg
2+
 ion nor chorismate or 
isochorismate are present. However, a sulfate ion occupies the position corresponding to 
location of C1 carboxylate, while the Glu241 sidechain flips to the surface of the protein 
opening up the active site cavity. Unfortunately, trials to crystallize DhbC with 
chorismate or isochorismate bound resulted in crystals diffracting to ~2.8 Å, which was 
not enough for accurate interpretation of the details of the protein-ligand interactions.  
The Lys142 of DhbC corresponds to Lys147 of E. coli EntC and Lys190 of 
E. coli MenF, which are thought to act as a catalytic base by activating a nucleophilic 
water molecule that is also hydrogen bonded to the C2 hydroxyl group of isochorismate 
(He and Toney 2006; Kolappan et al. 2007; Ziebart and Toney 2010). Lysine is 
conserved in this position in isochorismate and salicylate synthases, while anthranilate 
and ADC synthases have a glutamine or asparagine residue. In ADC synthases from E. 
coli (PDB entry 1k0e) (Parsons et al. 2002) and C. hutchinsonii (PDB entry 3h9m; New 
York SGX Research Center for Structural Genomics, unpublished work) corresponding 
positions are occupied by Glu210 and Glu182, respectively.  
The role of the general base for the loss of the C4 hydroxyl from chorismate is 
fulfilled by Glu197 (Glu197 in EntC and Glu240 in MenF) that points towards C4 of the 
bound isochorismate (Sridharan et al. 2010). 
The function of the two aromatic residues Phe328 and Tyr360, which form 
parallel-displaced -stacking interaction, oriented parallel to the expected position of 
chorismate ring, is unknown. The stacking interaction is present in E. coli isochorismate 
synthases, i.e., EntC and MenF. In the structure of MenF, the orientation of the aromatic 
pair Tyr368–Tyr399 is identical to DhbC. However, in the structure of EntC, aromatic 





pyruvyl group of chorismate as can be clearly seen in Figure 24. The F327Y EntC 
mutation results in a 48-fold decrease in enzyme efficiency, while the double mutant 
F327Y/I346L results in a 750-fold decrease of wild-type activity (Sridharan et al. 2010). 
Phe327 is conserved in DhbC and EntC, while in MenF and Irp9 it is substituted by 
tyrosine. The aromatic pair is not preserved in C. hutchinsonii ADC synthase 
(corresponding residues are Phe362 and Glu396; PDB entry 3h9m) and E. coli ADC 
synthase (Trp390 and Ser422; PDB entry 1k0e) and in salicylate synthase from 
Y. enterocolitica (Tyr372 and Gln403; PDB entry 2fn0) (Kerbarh et al. 2006). The 
presence of the stacking interaction in isochorismate synthases may be one of the 
functional determinants.  
In conclusion, Ala304 positions chorismate for nucleophilic attack at the C2 
position of chorismate by forming a hydrogen bond with the C2 hydroxyl. Lys142 is the 
catalytic base that activates the water molecule for nucleophilic attack at the C2 
hydroxyl group of chorismate via an Mg
2+
-bound transition state. Glu197 is a general 
acid for subsequent loss of the C4 hydroxyl (Domagalski et al. 2013). The SN2attack 
on C2 hydroxyl is a possible common mechanism for isochorismate synthase, salicylate 
synthase, anthranilate synthase, and ADC synthase. Subsequent events differentiate the 
enzymes, isochorismate synthase simply releases the product, while salicylate and 
anthranilate synthases additionally remove pyruvate, and ADC synthase performs 
second SN2 attack replacing C4 hydroxyl with amino group (He et al. 2004). 
6.8 DhbC as a potential drug target 
The exact role of isochorismate synthase DhbC in B. anthracis pathogenicity is 
not clear. The enzyme catalyzes the first step in the biosynthesis of catecholate 
siderophore bacillibactin, which is one of two siderophores produced by this organism. 
Studies on iron acquisition in B. anthracis showed that siderophores are essential for 
mouse virulence and that petrobactin, but not bacillibactin, is necessary for initiating 
infection in this model organism (Cendrowski et al. 2004). However, the authors of this 
research indicate that is does not necessarily exclude bacillibactin from playing a role in 
other host species. They note the example of mutagenesis in the Brucella abortus 
catechol siderophore biosynthetic pathway (brucebactin), which does not influence 





The B. anthracis infection has two stages: an establishment stage within phagocytes and 
an extracellular stage that leads to sepsis and death. The aforementioned study showed 
that petrobactin is key siderophore during the intracellular stage, but did not explain 
what happens during the extracellular stage of the infection. Other studies on 
siderophores secretion during B. anthracis spore germination and overgrowth in culture 
also indicated that spore development may need petrobactin early in an infection, while 
delayed bacillibactin production suggests that it plays a role in the later stages of 
infection (Wilson et al. 2010). The main reason for preferential expression of 
petrobactin at early stages of the infection is the fact that it is not recognizable by host 
protein siderocalin, which recognizes and deactivates catechol siderophores (Abergel et 
al. 2006). This feature of B. anthracis allows the anthrax bacteria to trick a host immune 
system. When the bacteria start to replicate rapidly and iron concentration drops down, 
expression of bacillibactin, which has much higher affinity for iron, is possibly 
triggered. The complex regulation of the bacillibactin operon expression by ferric 
uptake regulator (Fur), catabolite control protein A (CcpA) (Wunsche et al. 2012), 
oxygen depletion, and salinity suggests that bacillibactin is important for pathogenicity. 
It cannot be excluded that B. anthracis uses different sources of iron and therefore a 
different acquisition strategies depending on the route of infection. Recent studies on 
closely related species B. cereus (B. anthracis is a member of B. cereus sensu lato 
group) demonstrated that cooperation of bacillibactin and surface protein IlsA is crucial 
for iron acquisition from host ferritin and therefore effective virulence in insects 
(Segond et al. 2014). The B. anthracis genome encodes two proteins homologous to 
IslA, i.e., BslL, which is nearly identical to last three fourths of IlsA and BslK, which 
shares similarity with NEAT and SLH domains of IslA. BslK was shown to bind heme 
and mediate heme delivery to Isd system. Iron-regulated surface determinant (Isd) 
system of B. anthracis takes part in extraction of heme from hemoglobin during the 
extracellular phase of infection. It remains unknown if BslK, analogous to IslA, requires 
cooperation with bacillibactin. The proteins that consist on B. anthracis Isd system, i.e., 
IsdC (IDP05488), IsdJ (IDP05417), and IsdK (IDP02799) were selected for structure 
determination by CSGID. Unfortunately, thus far all experimental attempts for the 
proteins failed on expression or purification trials. Additional studies on the regulation 
of the B. anthracis asb and bac siderophore operons during the extracellular stage of 
infection and when heme is used as an iron source are necessary to elucidate if targeting 





Regardless of whether the bacillibactin production is necessary for B. anthracis 
pathogenicity, DhbC is still very promiscuous drug target. The product of its reaction, 
isochorismate is needed for synthesis of an important component of the electron 
transport chain, menaquinone. DhbC, but not the opposite can compensate lack of 
menaquinone biosynthesis-specific isochorismate synthase MenF. Sequence alignment 
of the two enzymes suggests that they share an active site composition and a catalytic 
mechanism, raising the chances to developing a single inhibitor compound for both 
enzymes. Moreover, a similar active site composition is characteristic for anthranilate 
synthase, salicylate synthase, aminodeoxychorismate synthase, and 2-amino-2-
desoxyisochorismate synthase, according to several crystal structures solved to date. 
The active site similarity suggests that all the aforementioned enzymes use a related 
mechanisms that includes the addition of either nitrogen or oxygen nucleophiles to C2 
of chorismate. The availability of multiple structures from this protein superfamily may 
allow finding a single inhibitor of chorismate-binding enzymes. Development of such 
compound requires a better understanding of the mechanistic features that differentiate 
catalytic activities of chorismate-binding enzymes.  
Succeeding studies of DhbC will focus on identifying the inhibitors of 
isochorismate synthase activity by structure-based virtual screening of large compound 
libraries. The effectiveness of multienzyme inhibitors identified by Ziebart (Ziebart et 







The result of this work is the three-dimensional structure of isochorismate 
synthase DhbC from B. anthracis, which was solved using the CSGID high-throughput 
gene-to-structure pipeline under control of the UniTrack data management system. 
The DhbC’s putative molecular function was confirmed and the enzyme was kinetically 
characterized using spectrophotometric assays. Because chorismate is a branch point 
metabolite in multiple solely bacterial pathways, DhbC and other chorismate-utilizing 
enzymes are promising targets in research for new generation of anti-pathogenic drugs. 
The structure of DhbC will guide the search for potent inhibitors of bacillibactin 
formation, and hence potentially of bacterial iron uptake. Development of key 
components of UniTrack was an essential part of this work. The system was designed to 
monitor, share, document, and publically release experimental details of the structure 
determination process for every CSGID protein target. The UniTrack-derived system 
consists of a central database of experimental data and a set of auxiliary databases and 
applications, which collect and integrate experimental data provided by distributed 
LIMSs in participating laboratories. Customized variants of the UniTrack system are 
deployed in the Center for Structural Genomics of Infectious Diseases, the Midwest 
Center for Structural Genomics, the New York Structural Genomics Consortium, and 
the Enzyme Function Initiative. The common components of the UniTrack-based data 
management system are a target tracking database, knowledge dissemination portal, 
target validation tool, communication scripts, and supporting databases. Additionally, 
instances used by NYSGRC and EFI are integrated with experiment the tracking system 
LabDB LIMS. The target tracking database stores data for all structure determination 
experiments of the CSGID, MCSG, NYSGRC, and EFI protein targets. The knowledge 
dissemination portal provides an access to experimental information, numerous statistics 
concerning general progress of the consortium and manual annotations for protein 
structures solved within the project. UniTrack makes the results and protocols for all 
steps of experimental pipeline starting from target selection to structure solution and 
deposition publicly available. Failed trails are also accessible, giving an overview on 
bottlenecks for a particular target and saving precious time for researchers that would 
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